Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_007294.3(BRCA1):c.*6207C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209219	17	41191488	17	43039471	209219	206177	rs78603756	NC_000017.11:43039470:G:A	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*5860C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209220	17	41191835	17	43039818	209220	206178	rs150356989	NC_000017.11:43039817:G:A	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*5678_*5679insAT	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209221	17	41192016 - 41192017	17	43039999 - 43040000	209221	206179	rs35578914	NC_000017.11:43039999:ATATA:ATATATA	Microsatellite		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*5513G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209222	17	41192182	17	43040165	209222	206180	rs112222971	NC_000017.11:43040164:C:T	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*4549G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209223	17	41193146	17	43041129	209223	206181	rs138528005	NC_000017.11:43041128:C:G	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*4271T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209224	17	41193424	17	43041407	209224	206182	rs13342026	NC_000017.11:43041406:A:T	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*4056C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209225	17	41193639	17	43041622	209225	206183	rs78612526	NC_000017.11:43041621:G:T	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*3785T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209226	17	41193910	17	43041893	209226	206184	rs8071278	NC_000017.11:43041892:A:T	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*2810A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209227	17	41194885	17	43042868	209227	206185	rs7223952	NC_000017.11:43042867:T:C	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*2670A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209228	17	41195025	17	43043008	209228	206186	rs11659028	NC_000017.11:43043007:T:A	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*2602C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209229	17	41195093	17	43043076	209229	206187	rs116585239	NC_000017.11:43043075:G:A	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*1984C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209230	17	41195711	17	43043694	209230	206188	rs8176323	NC_000017.11:43043693:G:C	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.*1922T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209231	17	41195773	17	43043756	209231	206189	rs8176322	NC_000017.11:43043755:A:G	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*1332G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209232	17	41196363	17	43044346	209232	206190	rs8176320	NC_000017.11:43044345:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*1327G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264789	17	41196368	17	43044351	264789	259533	rs184237074	NC_000017.11:43044350:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.*1287C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000132777	17	41196408	17	43044391	132777	136525	rs12516	NC_000017.11:43044390:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*1113G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209233	17	41196582	17	43044565	209233	206191	rs111791349	NC_000017.11:43044564:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*873del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264856	17	41196822	17	43044805	264856	259534	rs59541324	NC_000017.11:43044804:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTT	Deletion	3 prime UTR variant|non-coding transcript variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.*781C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000132778	17	41196914	17	43044897	132778	136526	rs8176319	NC_000017.11:43044896:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*750A>G	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	VCV000323414	17	41196945	17	43044928	323414	344643	rs138782023	NC_000017.11:43044927:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.*421G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209234	17	41197274	17	43045257	209234	206192	rs8176318	NC_000017.11:43045256:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*228A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209235	17	41197467	17	43045450	209235	206193	rs56108540	NC_000017.11:43045449:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*106C>T	BRCA1		Hereditary cancer-predisposing syndrome	VCV001332042	17	41197589	17	43045572	1332042	1322762	rs189442183	NC_000017.11:43045571:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 2, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.*36C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125873	17	41197659	17	43045642	125873	131411	rs3092995	NC_000017.11:43045641:G:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.*20C>T	BRCA1		Hereditary cancer-predisposing syndrome|not specified	VCV000182099	17	41197675	17	43045658	182099	180810	rs375042815	NC_000017.11:43045657:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5585A>T (p.His1862Leu)	BRCA1	H1862L, H1815L, H1883L, H758L, H1708L, H1751L, H1774L, H1790L, H1792L, H1818L, H1819L, H1857L, H1859L, H450L, H582L, H591L, H632L, H645L, H646L, H669L, H688L, H689L, H691L, H711L, H1735L, H1791L, H1821L, H1835L, H1842L, H1843L, H1858L, H1861L, H1884L, H670L, H677L, H687L, H710L, H716L, H717L, H720L, H733L, H734L, H1565L, H1566L, H1693L, H1733L, H1734L, H1750L, H1773L, H1778L, H1793L, H1794L, H1795L, H1814L, H1820L, H1834L, H1836L, H649L, H671L, H712L, H714L, H719L, H755L, H756L, H781L, H993L, H1749L, H1772L, H1813L, H1860L, H1882L, H631L, H650L, H679L, H692L, H718L, H732L, H757L, H759L, H780L, H994L	not provided|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055637	17	41197702	17	43045685	55637	70304	rs80357183	NC_000017.11:43045684:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Apr 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5576C>G (p.Pro1859Arg)	BRCA1	P1859R, P1812R, P755R, P1880R, P1879R, P447R, P579R, P629R, P666R, P676R, P707R, P708R, P713R, P714R, P730R, P756R, P777R, P1732R, P1747R, P1787R, P1788R, P1810R, P1816R, P1839R, P1854R, P588R, P646R, P647R, P667R, P685R, P688R, P709R, P711R, P754R, P991R, P1690R, P1769R, P1770R, P1771R, P1775R, P1789R, P1790R, P1791R, P1818R, P1858R, P642R, P684R, P716R, P717R, P729R, P731R, P753R, P990R, P1562R, P1730R, P1731R, P1748R, P1792R, P1815R, P1817R, P1831R, P1840R, P1855R, P1856R, P1881R, P628R, P643R, P668R, P674R, P686R, P689R, P715R, P752R, P778R, P1563R, P1705R, P1746R, P1811R, P1832R, P1833R, P1857R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055634	17	41197711	17	43045694	55634	70301	rs80357322	NC_000017.11:43045693:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5572A>C (p.Ile1858Leu)	BRCA1	I1858L, I1879L, I1811L, I754L, I1561L, I1562L, I1730L, I1745L, I1786L, I1789L, I1830L, I1831L, I1856L, I1857L, I1880L, I578L, I666L, I675L, I685L, I688L, I713L, I716L, I729L, I753L, I777L, I989L, I1689L, I1731L, I1747L, I1774L, I1788L, I1809L, I1810L, I1814L, I1832L, I1838L, I1839L, I446L, I628L, I645L, I667L, I673L, I687L, I706L, I707L, I708L, I715L, I751L, I752L, I776L, I642L, I683L, I710L, I714L, I728L, I755L, I1704L, I1787L, I1815L, I1817L, I1853L, I1854L, I1878L, I1729L, I1746L, I1768L, I1769L, I1770L, I1790L, I1791L, I1816L, I1855L, I587L, I627L, I641L, I646L, I665L, I684L, I712L, I730L, I990L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183951	17	41197715	17	43045698	183951	184864	rs765656957	NC_000017.11:43045697:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5544G>A (p.Gln1848=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000869025	17	41197743	17	43045726	869025	853118	rs2050865178	NC_000017.11:43045725:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant	Benign/Likely benign	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5531T>G (p.Leu1844Arg)	BRCA1	L1844R, L740R, L1865R, L1797R, L1732R, L1775R, L1776R, L1796R, L1801R, L1825R, L1841R, L1864R, L573R, L627R, L628R, L631R, L653R, L659R, L739R, L1675R, L1690R, L1754R, L1756R, L1760R, L1800R, L1803R, L1817R, L1842R, L1866R, L564R, L613R, L632R, L651R, L692R, L698R, L699R, L702R, L716R, L975R, L976R, L1548R, L1717R, L1731R, L1755R, L1772R, L1773R, L1802R, L1818R, L1824R, L1840R, L614R, L652R, L671R, L674R, L696R, L701R, L738R, L741R, L1547R, L1715R, L1716R, L1733R, L1774R, L1777R, L1795R, L1816R, L1839R, L1843R, L432R, L661R, L669R, L670R, L673R, L693R, L694R, L700R, L714R, L715R, L737R, L762R, L763R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055615	17	41197756	17	43045739	55615	70282	rs80357323	NC_000017.11:43045738:A:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5478G>C (p.Gln1826His)	BRCA1	Q722H, Q1779H, D698H, Q1847H, Q1826H, D1760H, D1800H, Q1529H, Q1715H, Q1737H, Q1738H, Q1755H, Q1777H, Q1783H, Q1784H, Q1799H, Q1800H, Q1806H, Q1822H, Q546H, Q555H, Q595H, Q633H, Q634H, Q635H, Q652H, Q680H, Q682H, Q696H, Q698H, Q719H, Q721H, Q957H, Q1759H, Q1798H, Q1807H, Q1821H, Q1824H, Q609H, Q613H, Q653H, Q681H, Q684H, Q720H, D1802H, Q1657H, Q1698H, Q1713H, Q1736H, Q1742H, Q1754H, Q1757H, Q1758H, D1754H, D1755H, D1801H, Q1530H, Q1697H, Q1699H, Q1778H, Q1782H, Q1825H, Q1846H, Q1848H, Q414H, Q610H, Q614H, Q655H, Q676H, Q723H, Q745H, Q958H, D1759H, D1761H, D697H, Q1672H, Q1714H, Q1756H, Q1785H, Q1823H, Q596H, Q641H, Q643H, Q651H, Q656H, Q674H, Q675H, Q678H, Q683H, Q697H, Q744H	Hereditary cancer-predisposing syndrome	VCV000864919	17	41197809	17	43045792	864919	853244	rs80357332	NC_000017.11:43045791:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 19, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5468-3C>T	BRCA1		Hereditary cancer-predisposing syndrome	VCV000868962	17	41197822	17	43045805	868962	855124	rs1567756806	NC_000017.11:43045804:G:A	single nucleotide variant	intron variant	Benign	Aug 20, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5468-4C>A	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000825757	17	41197823	17	43045806	825757	815683	rs763484977	NC_000017.11:43045805:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5468-8G>C	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000867564	17	41197827	17	43045810	867564	855137	rs1597797270	NC_000017.11:43045809:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5468-10_5468-9del	BRCA1		not provided|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091652	17	41197828 - 41197829	17	43045811 - 43045812	91652	97129	rs273902770	NC_000017.11:43045810:AGAGA:AGA	Microsatellite	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5468-10C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055589	17	41197829	17	43045812	55589	70256	rs8176316	NC_000017.11:43045811:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5468-121dup	BRCA1		not provided	VCV001228544	17	41197939 - 41197940	17	43045922 - 43045923	1228544	1218548	rs375078966	NC_000017.11:43045922:TTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Aug 13, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5468-268A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209236	17	41198087	17	43046070	209236	206194	rs181430678	NC_000017.11:43046069:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5468-451C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209237	17	41198270	17	43046253	209237	206195	rs147297981	NC_000017.11:43046252:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5468-802T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209238	17	41198621	17	43046604	209238	206196	rs8176314	NC_000017.11:43046603:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5467+885dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264834	17	41198774 - 41198775	17	43046757 - 43046758	264834	259535	rs370148636	NC_000017.11:43046757:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5467+712C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209239	17	41198948	17	43046931	209239	206197	rs139237482	NC_000017.11:43046930:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5467+658G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209240	17	41199002	17	43046985	209240	206198	rs8176313	NC_000017.11:43046984:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5467+537A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209241	17	41199123	17	43047106	209241	206199	rs8176312	NC_000017.11:43047105:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5467+482C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209242	17	41199178	17	43047161	209242	206200	rs8068463	NC_000017.11:43047160:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5467+9C>T	BRCA1		Hereditary breast ovarian cancer syndrome|not provided	VCV000125853	17	41199651	17	43047634	125853	131391	rs80358031	NC_000017.11:43047633:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5456A>G (p.Asn1819Ser)	BRCA1	N1819S, N1840S, N715S, N1772S, N1665S, N1692S, N1731S, N1748S, N1751S, N1776S, N1777S, N1792S, N1814S, N1839S, N407S, N539S, N589S, N626S, N628S, N636S, N644S, N667S, N668S, N675S, N676S, N712S, N713S, N716S, N738S, N950S, N951S, N1523S, N1691S, N1708S, N1729S, N1735S, N1749S, N1750S, N1800S, N1815S, N1817S, N602S, N606S, N673S, N674S, N677S, N690S, N1522S, N1690S, N1706S, N1730S, N1771S, N1778S, N1793S, N1816S, N548S, N588S, N603S, N607S, N645S, N648S, N649S, N737S, N1650S, N1707S, N1747S, N1752S, N1770S, N1775S, N1791S, N1799S, N1818S, N1841S, N627S, N634S, N646S, N669S, N671S, N689S, N691S, N714S	Hereditary cancer-predisposing syndrome|Familial pancreatic carcinoma|Hereditary breast ovarian cancer syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000055585	17	41199671	17	43047654	55585	70252	rs80357286	NC_000017.11:43047653:T:C	single nucleotide variant	missense variant|synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5411T>A (p.Val1804Asp)	BRCA1	V1804D, C675*, V1757D, V1825D, V700D, C1779*, V1676D, V1716D, V1720D, V1732D, V1735D, V1756D, V1761D, V1777D, V1785D, V1801D, V1824D, V574D, V613D, V630D, V631D, V675D, V699D, V935D, C1778*, V1507D, V1635D, V1675D, V1733D, V1734D, V1736D, V1737D, V1763D, V1800D, V1826D, V392D, V573D, V587D, V588D, V611D, V653D, V658D, V659D, V662D, V698D, V723D, C1731*, C674*, V1691D, V1692D, V1715D, V1760D, V1762D, V1776D, V1778D, V1784D, V524D, V591D, V612D, V619D, V621D, V629D, V634D, V656D, V661D, V674D, V936D, C1732*, C1736*, C1737*, C1738*, C1777*, V1508D, V1650D, V1677D, V1693D, V1714D, V1755D, V1799D, V1802D, V1803D, V533D, V592D, V633D, V652D, V654D, V660D, V676D, V697D, V701D, V722D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055568	17	41199716	17	43047699	55568	70235	rs80356920	NC_000017.11:43047698:A:T	single nucleotide variant	missense variant|nonsense|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5409T>C (p.Gly1803=)	BRCA1	C675R, C1731R, C1737R, C1738R, C674R, C1778R, C1779R, C1777R, C1732R, C1736R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000868463	17	41199718	17	43047701	868463	853393	rs2050995166	NC_000017.11:43047700:A:G	single nucleotide variant	synonymous variant|missense variant	Benign/Likely benign	Jan 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5407-7del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002149163	17	41199727	17	43047710	2149163	1877611	rs2152814538	NC_000017.11:43047709:CCCC:CCC	Deletion	intron variant	Benign	Aug 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5407-12C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000868068	17	41199732	17	43047715	868068	855225	rs1432221089	NC_000017.11:43047714:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5407-193A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209243	17	41199913	17	43047896	209243	206201	rs8176310	NC_000017.11:43047895:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5407-389A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209244	17	41200109	17	43048092	209244	206202	rs4793190	NC_000017.11:43048091:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+603GA[5]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209245	17	41200524 - 41200525	17	43048507 - 43048508	209245	206203	rs200225694	NC_000017.11:43048506:TCTCTCTCTCTCT:TCTCTCTCTCT	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+601_5406+602insG	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209246	17	41200536 - 41200537	17	43048519 - 43048520	209246	206204	rs200489356	NC_000017.11:43048519::C	Insertion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+601A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209247	17	41200537	17	43048520	209247	206205	rs4792972	NC_000017.11:43048519:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+296G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264799	17	41200842	17	43048825	264799	259536	rs73311445	NC_000017.11:43048824:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+68T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125842	17	41201070	17	43049053	125842	131380	rs8176307	NC_000017.11:43049052:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+33A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055561	17	41201105	17	43049088	55561	70228	rs80358092	NC_000017.11:43049087:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406+8T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125843	17	41201130	17	43049113	125843	131381	rs55946644	NC_000017.11:43049112:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5406A>G (p.Thr1802=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000868056	17	41201138	17	43049121	868056	853398	rs879255493	NC_000017.11:43049120:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5347A>T (p.Met1783Leu)	BRCA1	M679L, M1736L, M1783L, M1804L, M1486L, M1654L, M1670L, M1671L, M1712L, M1715L, M1741L, M1757L, M1763L, M503L, M512L, M552L, M567L, M609L, M637L, M640L, M677L, M1629L, M1672L, M1693L, M1713L, M1714L, M1734L, M1739L, M1778L, M1781L, M1782L, M1803L, M600L, M612L, M613L, M632L, M638L, M653L, M655L, M676L, M915L, M1614L, M1656L, M1695L, M1711L, M1740L, M1779L, M1805L, M553L, M571L, M590L, M591L, M592L, M608L, M633L, M635L, M639L, M680L, M702L, M1487L, M1655L, M1694L, M1716L, M1735L, M1742L, M1755L, M1756L, M1764L, M1780L, M371L, M566L, M570L, M598L, M610L, M631L, M641L, M654L, M678L, M701L, M914L	Hereditary breast ovarian cancer syndrome	VCV000865370	17	41201197	17	43049180	865370	853523	rs80357012	NC_000017.11:43049179:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Jul 20, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5334T>C (p.Asp1778=)	BRCA1		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000186289	17	41201210	17	43049193	186289	184876	rs754152768	NC_000017.11:43049192:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5333-134C>A	BRCA1		Hereditary cancer-predisposing syndrome	VCV000491110	17	41201345	17	43049328	491110	484997	rs8176306	NC_000017.11:43049327:G:T	single nucleotide variant	intron variant	Benign	May 10, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5333-153A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209248	17	41201364	17	43049347	209248	206206	rs8176305	NC_000017.11:43049346:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5333-221C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209249	17	41201432	17	43049415	209249	206207	rs8176304	NC_000017.11:43049414:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5333-254A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209250	17	41201465	17	43049448	209250	206208	rs8176303	NC_000017.11:43049447:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5333-304G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209251	17	41201515	17	43049498	209251	206209	rs55633264	NC_000017.11:43049497:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5333-491G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209252	17	41201702	17	43049685	209252	206210	rs3092988	NC_000017.11:43049684:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+501C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209253	17	41202579	17	43050562	209253	206211	rs12949768	NC_000017.11:43050561:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+490T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209254	17	41202590	17	43050573	209254	206212	rs11079053	NC_000017.11:43050572:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+454del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209255	17	41202626	17	43050609	209255	206213	rs35805899	NC_000017.11:43050608:AAAAAAAAA:AAAAAAAA	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+392C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209256	17	41202688	17	43050671	209256	206214	rs8070179	NC_000017.11:43050670:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+185A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209257	17	41202895	17	43050878	209257	206215	rs8176298	NC_000017.11:43050877:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+182dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209258	17	41202897 - 41202898	17	43050880 - 43050881	209258	206216	rs201644509	NC_000017.11:43050880:TTTTTTTTT:TTTTTTTTTT	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5332+19C>T	BRCA1		not specified|Hereditary breast ovarian cancer syndrome	VCV000377574	17	41203061	17	43051044	377574	376083	rs774813458	NC_000017.11:43051043:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5332+13G>T	BRCA1		not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000220900	17	41203067	17	43051050	220900	222647	rs372391060	NC_000017.11:43051049:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5331A>T (p.Thr1777=)	BRCA1		Hereditary cancer-predisposing syndrome|BRCA1-related cancer predisposition	VCV000867999	17	41203081	17	43051064	867999	853547	rs1411246255	NC_000017.11:43051063:T:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-14C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091645	17	41203148	17	43051131	91645	97122	rs80358105	NC_000017.11:43051130:G:C	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-20C>T	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000379110	17	41203154	17	43051137	379110	375046	rs193149108	NC_000017.11:43051136:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5278-191A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209259	17	41203325	17	43051308	209259	206217	rs8176297	NC_000017.11:43051307:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-457A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209260	17	41203591	17	43051574	209260	206218	rs8176296	NC_000017.11:43051573:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-464G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264794	17	41203598	17	43051581	264794	259537	rs545723152	NC_000017.11:43051580:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-542G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264820	17	41203676	17	43051659	264820	259538	rs139210193	NC_000017.11:43051658:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-554GA[2]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264832	17	41203681 - 41203684	17	43051664 - 43051667	264832	259539	rs538015792	NC_000017.11:43051663:TCTCTCTCT:TCTCT	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-573C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209261	17	41203707	17	43051690	209261	206219	rs143338062	NC_000017.11:43051689:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-866G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209262	17	41204000	17	43051983	209262	206220	rs148509734	NC_000017.11:43051982:C:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-884A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209263	17	41204018	17	43052001	209263	206221	rs113892722	NC_000017.11:43052000:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1071G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209264	17	41204205	17	43052188	209264	206222	rs150614759	NC_000017.11:43052187:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1227C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209265	17	41204361	17	43052344	209265	206223	rs111563453	NC_000017.11:43052343:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1243T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209266	17	41204377	17	43052360	209266	206224	rs4793191	NC_000017.11:43052359:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1256A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209267	17	41204390	17	43052373	209267	206225	rs4793192	NC_000017.11:43052372:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1519A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209268	17	41204653	17	43052636	209268	206226	rs114112971	NC_000017.11:43052635:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1644A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209269	17	41204778	17	43052761	209269	206227	rs34685631	NC_000017.11:43052760:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1722C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209270	17	41204856	17	43052839	209270	206228	rs17671533	NC_000017.11:43052838:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1766A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209271	17	41204900	17	43052883	209271	206229	rs117151230	NC_000017.11:43052882:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1874G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209272	17	41205008	17	43052991	209272	206230	rs8176295	NC_000017.11:43052990:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-1918G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209273	17	41205052	17	43053035	209273	206231	rs149958317	NC_000017.11:43053034:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2237del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209274	17	41205371	17	43053354	209274	206232	rs8176293	NC_000017.11:43053353:TT:T	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2498G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209275	17	41205632	17	43053615	209275	206233	rs182249140	NC_000017.11:43053614:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2587C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209276	17	41205721	17	43053704	209276	206234	rs6503725	NC_000017.11:43053703:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2638C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209277	17	41205772	17	43053755	209277	206235	rs8176290	NC_000017.11:43053754:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2807T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209278	17	41205941	17	43053924	209278	206236	rs7212284	NC_000017.11:43053923:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2922A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209279	17	41206056	17	43054039	209279	206237	rs8176289	NC_000017.11:43054038:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5278-2963G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209280	17	41206097	17	43054080	209280	206238	rs78695654	NC_000017.11:43054079:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+2938T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264859	17	41206131	17	43054114	264859	259540	rs8176288	NC_000017.11:43054113:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+2439T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209281	17	41206630	17	43054613	209281	206239	rs143042094	NC_000017.11:43054612:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+2307del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264843	17	41206762	17	43054745	264843	259541	rs11347376	NC_000017.11:43054744:TTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTT	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+2217A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209282	17	41206852	17	43054835	209282	206240	rs8176287	NC_000017.11:43054834:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+2029G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264851	17	41207040	17	43055023	264851	259542	rs371465813	NC_000017.11:43055022:C:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+1607G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209283	17	41207462	17	43055445	209283	206241	rs62076408	NC_000017.11:43055444:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+1409G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209284	17	41207660	17	43055643	209284	206242	rs36113921	NC_000017.11:43055642:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+861G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264840	17	41208208	17	43056191	264840	259543	rs372544924	NC_000017.11:43056190:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+853T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209285	17	41208216	17	43056199	209285	206243	rs116703787	NC_000017.11:43056198:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+764G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209286	17	41208305	17	43056288	209286	206244	rs112757145	NC_000017.11:43056287:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+602T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209287	17	41208467	17	43056450	209287	206245	rs8176286	NC_000017.11:43056449:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+365del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209288	17	41208704	17	43056687	209288	206246	rs201212001	NC_000017.11:43056686:G:	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+315T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264833	17	41208754	17	43056737	264833	259544	rs183831660	NC_000017.11:43056736:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+186T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264830	17	41208883	17	43056866	264830	259545	rs8176284	NC_000017.11:43056865:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+78G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125817	17	41208991	17	43056974	125817	131355	rs80358107	NC_000017.11:43056973:C:T	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+48_5277+59dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433729	17	41209009 - 41209010	17	43056992 - 43056993	433729	427527	rs572766355	NC_000017.11:43056992:GGAGTGGAATAC:GGAGTGGAATACGGAGTGGAATAC	Duplication	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5277+42C>A	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001325652	17	41209027	17	43057010	1325652	1315917	rs537848419	NC_000017.11:43057009:G:T	single nucleotide variant	intron variant	Benign	Nov 16, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5277+20G>A	BRCA1		not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000220103	17	41209049	17	43057032	220103	222649	rs766950602	NC_000017.11:43057031:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5252G>A (p.Arg1751Gln)	BRCA1	R1751Q, R1704Q, R1772Q, R647Q, R1455Q, R1639Q, R1662Q, R1680Q, R1681Q, R1710Q, R1747Q, R1771Q, R1773Q, R539Q, R559Q, R580Q, R600Q, R601Q, R623Q, R646Q, R669Q, R1582Q, R1623Q, R1624Q, R1661Q, R1679Q, R1684Q, R1708Q, R1709Q, R1732Q, R1746Q, R1750Q, R339Q, R471Q, R560Q, R576Q, R599Q, R603Q, R609Q, R644Q, R882Q, R1454Q, R1597Q, R1682Q, R1703Q, R1723Q, R1748Q, R480Q, R534Q, R577Q, R578Q, R581Q, R605Q, R606Q, R621Q, R648Q, R883Q, R1622Q, R1638Q, R1640Q, R1663Q, R1683Q, R1702Q, R1707Q, R1724Q, R1725Q, R1731Q, R1749Q, R520Q, R521Q, R535Q, R538Q, R558Q, R566Q, R568Q, R607Q, R608Q, R622Q, R645Q, R670Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055481	17	41209094	17	43057077	55481	70148	rs80357442	NC_000017.11:43057076:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5198A>G (p.Asp1733Gly)	BRCA1	D1733G, D1754G, D629G, D1686G, D1564G, D1604G, D1645G, D1661G, D1665G, D1684G, D1692G, D1705G, D1706G, D1728G, D502G, D517G, D550G, D581G, D603G, D605G, D626G, D1436G, D1605G, D1606G, D1644G, D1662G, D1664G, D1691G, D1714G, D1730G, D1732G, D503G, D542G, D548G, D562G, D585G, D587G, D627G, D1437G, D1579G, D1620G, D1643G, D1663G, D1685G, D1690G, D1713G, D1729G, D1731G, D453G, D462G, D520G, D559G, D560G, D563G, D582G, D589G, D630G, D652G, D865G, D1621G, D1622G, D1666G, D1689G, D1707G, D1753G, D1755G, D321G, D516G, D521G, D540G, D541G, D558G, D583G, D588G, D590G, D591G, D604G, D628G, D651G, D864G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055453	17	41209148	17	43057131	55453	70120	rs80357270	NC_000017.11:43057130:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-4T>G	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000865145	17	41209156	17	43057139	865145	855417	rs1057524456	NC_000017.11:43057138:A:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5194-16G>A	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|not specified	VCV000633090	17	41209168	17	43057151	633090	621858	rs368058346	NC_000017.11:43057150:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5194-18G>T	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000125803	17	41209170	17	43057153	125803	131341	rs80358090	NC_000017.11:43057152:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5194-221T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209289	17	41209373	17	43057356	209289	206247	rs111611613	NC_000017.11:43057355:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-403T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264854	17	41209555	17	43057538	264854	259546	rs559234080	NC_000017.11:43057537:A:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-423C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209290	17	41209575	17	43057558	209290	206248	rs149635371	NC_000017.11:43057557:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-426A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209291	17	41209578	17	43057561	209291	206249	rs8176282	NC_000017.11:43057560:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-466G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209292	17	41209618	17	43057601	209292	206250	rs8176281	NC_000017.11:43057600:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-475G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209293	17	41209627	17	43057610	209293	206251	rs8176280	NC_000017.11:43057609:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-1179G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209294	17	41210331	17	43058314	209294	206252	rs8066171	NC_000017.11:43058313:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-1242T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209295	17	41210394	17	43058377	209295	206253	rs146318688	NC_000017.11:43058376:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-1244T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209296	17	41210396	17	43058379	209296	206254	rs8176279	NC_000017.11:43058378:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-1264A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209297	17	41210416	17	43058399	209297	206255	rs8176278	NC_000017.11:43058398:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-1450A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209298	17	41210602	17	43058585	209298	206256	rs8176276	NC_000017.11:43058584:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2072G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209299	17	41211224	17	43059207	209299	206257	rs181752925	NC_000017.11:43059206:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2216G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209300	17	41211368	17	43059351	209300	206258	rs142638930	NC_000017.11:43059350:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2379TGT[16]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264857	17	41211486 - 41211487	17	43059469 - 43059470	264857	259547	rs746155740	NC_000017.11:43059469:ACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAA:ACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAA	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2381T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264816	17	41211533	17	43059516	264816	259548	rs186594388	NC_000017.11:43059515:A:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2501T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209301	17	41211653	17	43059636	209301	206259	rs8176273	NC_000017.11:43059635:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2801A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209302	17	41211953	17	43059936	209302	206260	rs185244474	NC_000017.11:43059935:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-2912T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264810	17	41212064	17	43060047	264810	259549	rs189676688	NC_000017.11:43060046:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-3017G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209303	17	41212169	17	43060152	209303	206261	rs11652377	NC_000017.11:43060151:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5194-3028G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209304	17	41212180	17	43060163	209304	206262	rs146959162	NC_000017.11:43060162:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+3012T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209305	17	41212338	17	43060321	209305	206263	rs4793193	NC_000017.11:43060320:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2803G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209306	17	41212547	17	43060530	209306	206264	rs35330014	NC_000017.11:43060529:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2588C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209307	17	41212762	17	43060745	209307	206265	rs111581719	NC_000017.11:43060744:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2582G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264803	17	41212768	17	43060751	264803	259550	rs186421008	NC_000017.11:43060750:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2545G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209308	17	41212805	17	43060788	209308	206266	rs8077486	NC_000017.11:43060787:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2337G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209309	17	41213013	17	43060996	209309	206267	rs115522763	NC_000017.11:43060995:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2256C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209310	17	41213094	17	43061077	209310	206268	rs141915184	NC_000017.11:43061076:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2230C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209311	17	41213120	17	43061103	209311	206269	rs146299550	NC_000017.11:43061102:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+2032G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209312	17	41213318	17	43061301	209312	206270	rs139650794	NC_000017.11:43061300:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1724C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209313	17	41213626	17	43061609	209313	206271	rs8176269	NC_000017.11:43061608:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1690A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209314	17	41213660	17	43061643	209314	206272	rs8176268	NC_000017.11:43061642:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1602A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209315	17	41213748	17	43061731	209315	206273	rs8176267	NC_000017.11:43061730:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1590G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209316	17	41213760	17	43061743	209316	206274	rs8176266	NC_000017.11:43061742:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1457G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209317	17	41213893	17	43061876	209317	206275	rs2187603	NC_000017.11:43061875:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1354G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209318	17	41213996	17	43061979	209318	206276	rs8176265	NC_000017.11:43061978:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1271A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209319	17	41214079	17	43062062	209319	206277	rs8176264	NC_000017.11:43062061:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1232_5193+1234del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264817	17	41214116 - 41214118	17	43062099 - 43062101	264817	259551	rs536209322	NC_000017.11:43062098:TTTTTTTTTTTT:TTTTTTTTT	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+1139_5193+1140del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209320	17	41214210 - 41214211	17	43062193 - 43062194	209320	206278	rs8176263	NC_000017.11:43062192:AA:	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+730A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209321	17	41214620	17	43062603	209321	206279	rs186955850	NC_000017.11:43062602:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5193+3A>T	BRCA1		Hereditary cancer-predisposing syndrome	VCV000868130	17	41215347	17	43063330	868130	855507	rs1060502326	NC_000017.11:43063329:T:A	single nucleotide variant	intron variant	Benign	Dec 29, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5158A>G (p.Thr1720Ala)	BRCA1	T1720A, T616A, T1673A, T1741A, T1423A, T1630A, T1648A, T1649A, T1650A, T1652A, T1653A, T1672A, T1679A, T1716A, T1718A, T1742A, T308A, T440A, T503A, T504A, T508A, T546A, T549A, T617A, T1424A, T1566A, T1591A, T1592A, T1608A, T1700A, T1717A, T489A, T490A, T529A, T572A, T576A, T590A, T1609A, T1631A, T1651A, T1676A, T1677A, T1678A, T1692A, T1701A, T1715A, T527A, T537A, T547A, T550A, T568A, T575A, T591A, T592A, T615A, T638A, T639A, T851A, T852A, T1551A, T1593A, T1607A, T1632A, T1671A, T1693A, T1694A, T1719A, T1740A, T449A, T507A, T528A, T535A, T545A, T569A, T570A, T574A, T577A, T578A, T613A, T614A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055438	17	41215385	17	43063368	55438	70105	rs56195342	NC_000017.11:43063367:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153-4T>C	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000867744	17	41215394	17	43063377	867744	855516	rs2051873522	NC_000017.11:43063376:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5153-6C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000096941	17	41215396	17	43063379	96941	102844	rs80358129	NC_000017.11:43063378:G:T	single nucleotide variant	intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5153-13A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125783	17	41215403	17	43063386	125783	131321	rs45471406	NC_000017.11:43063385:T:C	single nucleotide variant	intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5152+188dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264842	17	41215702 - 41215703	17	43063685 - 43063686	264842	259552	rs542231412	NC_000017.11:43063685:TTTT:TTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5152+85del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125782	17	41215806	17	43063789	125782	131320	rs8176259	NC_000017.11:43063788:AAAAA:AAAA	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5152+66G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055428	17	41215825	17	43063808	55428	70095	rs3092994	NC_000017.11:43063807:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5152+20T>A	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000132704	17	41215871	17	43063854	132704	136452	rs376836050	NC_000017.11:43063853:A:T	single nucleotide variant	intron variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+12A>G	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 2	VCV002148450	17	41215879	17	43063862	2148450	1880778	rs756586490	NC_000017.11:43063861:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jul 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5152+10A>G	BRCA1		Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Breast and/or ovarian cancer|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037641	17	41215881	17	43063864	37641	46197	rs80358114	NC_000017.11:43063863:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5118A>T (p.Gly1706=)	BRCA1		Hereditary cancer-predisposing syndrome	VCV000869054	17	41215925	17	43063908	869054	853949	rs2051919981	NC_000017.11:43063907:T:A	single nucleotide variant	synonymous variant|intron variant	Benign	Apr 16, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	BRCA1	G1706A, G1659A, G602A, G1727A, G1409A, G1595A, G1665A, G1703A, G426A, G435A, G489A, G493A, G494A, G521A, G523A, G555A, G556A, G558A, G560A, G576A, G578A, G599A, G838A, G1552A, G1577A, G1616A, G1617A, G1634A, G1636A, G1637A, G1658A, G1679A, G1680A, G1686A, G1704A, G294A, G514A, G564A, G600A, G624A, G1594A, G1639A, G1657A, G1663A, G1678A, G1702A, G1705A, G513A, G535A, G561A, G562A, G563A, G601A, G603A, G625A, G837A, G1410A, G1537A, G1578A, G1579A, G1593A, G1618A, G1635A, G1662A, G1664A, G1687A, G1701A, G1726A, G1728A, G475A, G476A, G490A, G515A, G531A, G532A, G533A, G536A, G554A, G577A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055406	17	41215926	17	43063909	55406	70073	rs80356860	NC_000017.11:43063908:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-9A>T	BRCA1		not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000125761	17	41215977	17	43063960	125761	131299	rs80358059	NC_000017.11:43063959:T:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5075-53C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125760	17	41216021	17	43064004	125760	131298	rs8176258	NC_000017.11:43064003:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-237C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209322	17	41216205	17	43064188	209322	206280	rs8176257	NC_000017.11:43064187:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-238A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209323	17	41216206	17	43064189	209323	206281	rs8176256	NC_000017.11:43064188:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-373C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209324	17	41216341	17	43064324	209324	206282	rs8176255	NC_000017.11:43064323:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-376C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209325	17	41216344	17	43064327	209325	206283	rs8176254	NC_000017.11:43064326:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-745A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209326	17	41216713	17	43064696	209326	206284	rs8176252	NC_000017.11:43064695:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-965A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209327	17	41216933	17	43064916	209327	206285	rs3785546	NC_000017.11:43064915:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1073C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209328	17	41217041	17	43065024	209328	206286	rs8176250	NC_000017.11:43065023:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1135G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209329	17	41217103	17	43065086	209329	206287	rs8176248	NC_000017.11:43065085:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1139del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209330	17	41217107	17	43065090	209330	206288	rs8176247	NC_000017.11:43065089:AAA:AA	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1143G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209331	17	41217111	17	43065094	209331	206289	rs8176246	NC_000017.11:43065093:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1412T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209332	17	41217380	17	43065363	209332	206290	rs8176245	NC_000017.11:43065362:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1546A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209333	17	41217514	17	43065497	209333	206291	rs8176244	NC_000017.11:43065496:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5075-1584T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209334	17	41217552	17	43065535	209334	206292	rs8176243	NC_000017.11:43065534:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1751G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209335	17	41217874	17	43065857	209335	206293	rs8176242	NC_000017.11:43065856:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1618A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264815	17	41218007	17	43065990	264815	259553	rs139038134	NC_000017.11:43065989:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1388A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264858	17	41218237	17	43066220	264858	259554	rs145654477	NC_000017.11:43066219:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1292C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209336	17	41218333	17	43066316	209336	206294	rs4793194	NC_000017.11:43066315:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1253T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209337	17	41218372	17	43066355	209337	206295	rs8176240	NC_000017.11:43066354:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1199C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209338	17	41218426	17	43066409	209338	206296	rs8176239	NC_000017.11:43066408:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1158G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209339	17	41218467	17	43066450	209339	206297	rs112966361	NC_000017.11:43066449:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1053A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209340	17	41218572	17	43066555	209340	206298	rs4793195	NC_000017.11:43066554:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+1010T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209341	17	41218615	17	43066598	209341	206299	rs142829210	NC_000017.11:43066597:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+918G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264837	17	41218707	17	43066690	264837	259555	rs8176238	NC_000017.11:43066689:C:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+918G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209342	17	41218707	17	43066690	209342	206300	rs8176238	NC_000017.11:43066689:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+909C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209343	17	41218716	17	43066699	209343	206301	rs139793550	NC_000017.11:43066698:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+878G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209344	17	41218747	17	43066730	209344	206302	rs8176237	NC_000017.11:43066729:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+820T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209345	17	41218805	17	43066788	209345	206303	rs8176236	NC_000017.11:43066787:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+760G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264788	17	41218865	17	43066848	264788	259556	rs533045755	NC_000017.11:43066847:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+284C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000127127	17	41219341	17	43067324	127127	132630	rs11654396	NC_000017.11:43067323:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+265G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209346	17	41219360	17	43067343	209346	206304	rs147144902	NC_000017.11:43067342:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+228C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209347	17	41219397	17	43067380	209347	206305	rs71379207	NC_000017.11:43067379:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+221A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209348	17	41219404	17	43067387	209348	206306	rs142117419	NC_000017.11:43067386:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+205G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209349	17	41219420	17	43067403	209349	206307	rs113814958	NC_000017.11:43067402:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+65G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000127126	17	41219560	17	43067543	127126	132629	rs8176235	NC_000017.11:43067542:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5074+57C>T	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002075140	17	41219568	17	43067551	2075140	2134255	rs564362551	NC_000017.11:43067550:G:A	single nucleotide variant	intron variant	Benign	Nov 5, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.5074+23A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000371973	17	41219602	17	43067585	371973	358933	rs778115859	NC_000017.11:43067584:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jul 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.5074+6C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091636	17	41219619	17	43067602	91636	97113	rs80358032	NC_000017.11:43067601:G:C	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.5044G>A (p.Glu1682Lys)	BRCA1	E1682K, E1635K, E1703K, E578K, E1513K, E1569K, E1594K, E1610K, E1613K, E1656K, E1662K, E1663K, E1678K, E1679K, E1702K, E402K, E1385K, E1553K, E1592K, E1634K, E1638K, E1639K, E1640K, E1654K, E1704K, E452K, E489K, E490K, E491K, E497K, E512K, E530K, E537K, E540K, E553K, E813K, E1386K, E1555K, E1571K, E1633K, E1655K, E1677K, E1680K, E1681K, E451K, E507K, E531K, E532K, E575K, E576K, E411K, E466K, E499K, E508K, E538K, E552K, E554K, E579K, E600K, E1528K, E1554K, E1570K, E1593K, E1611K, E1612K, E1615K, E1641K, E465K, E469K, E470K, E509K, E511K, E534K, E536K, E539K, E577K, E601K, E814K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055361	17	41219655	17	43067638	55361	70028	rs80356958	NC_000017.11:43067637:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.5024C>T (p.Thr1675Ile)	BRCA1	T1675I, T1696I, T1628I, T571I, T1506I, T1521I, T1562I, T1586I, T1606I, T1627I, T1631I, T1647I, T1648I, T1697I, T444I, T445I, T459I, T462I, T463I, T530I, T547I, T807I, T1563I, T1587I, T1603I, T1632I, T1649I, T1656I, T1674I, T1695I, T395I, T482I, T483I, T484I, T492I, T501I, T523I, T525I, T531I, T533I, T546I, T568I, T594I, T1378I, T1379I, T1546I, T1548I, T1585I, T1604I, T1605I, T1608I, T1626I, T1633I, T1634I, T1670I, T1671I, T1672I, T1673I, T490I, T502I, T545I, T569I, T572I, T593I, T1547I, T1564I, T1655I, T404I, T458I, T500I, T504I, T505I, T524I, T527I, T529I, T532I, T570I, T806I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000240811	17	41219675	17	43067658	240811	242767	rs150729791	NC_000017.11:43067657:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4992C>T (p.Leu1664=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136551	17	41219707	17	43067690	136551	140254	rs142459158	NC_000017.11:43067689:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4991T>C (p.Leu1664Pro)	BRCA1	L1664P, L1685P, L1617P, L560P, L1368P, L1510P, L1615P, L1622P, L1659P, L1684P, L1686P, L384P, L447P, L452P, L472P, L491P, L493P, L512P, L513P, L559P, L561P, L582P, L583P, L1495P, L1537P, L1593P, L1620P, L1637P, L1638P, L1661P, L1662P, L393P, L434P, L479P, L481P, L494P, L520P, L534P, L535P, L536P, L796P, L1535P, L1574P, L1576P, L1592P, L1594P, L1597P, L1623P, L1663P, L473P, L490P, L516P, L519P, L522P, L557P, L558P, L795P, L1367P, L1536P, L1551P, L1552P, L1553P, L1575P, L1595P, L1616P, L1621P, L1636P, L1644P, L1645P, L1660P, L433P, L448P, L451P, L471P, L489P, L514P, L518P, L521P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037621	17	41219708	17	43067691	37621	46177	rs80357314	NC_000017.11:43067690:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-4T>G	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000489726	17	41219716	17	43067699	489726	483008	rs1157151499	NC_000017.11:43067698:A:C	single nucleotide variant	intron variant	Benign/Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4987-20A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091635	17	41219732	17	43067715	91635	97112	rs80358035	NC_000017.11:43067714:T:C	single nucleotide variant	intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-68A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125746	17	41219780	17	43067763	125746	131284	rs8176234	NC_000017.11:43067762:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-92A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125749	17	41219804	17	43067787	125749	131287	rs8176233	NC_000017.11:43067786:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-144_4987-142dup	BRCA1		not specified	VCV003911260	17	41219853 - 41219854	17	43067836 - 43067837	3911260	4025235		NC_000017.11:43067836:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Feb 16, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-143_4987-142dup	BRCA1		not provided	VCV001270698	17	41219853 - 41219854	17	43067836 - 43067837	1270698	1261835	rs11421283	NC_000017.11:43067836:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Aug 7, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-145_4987-142dup	BRCA1		not provided	VCV001266215	17	41219853 - 41219854	17	43067836 - 43067837	1266215	1256546	rs11421283	NC_000017.11:43067836:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Aug 19, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-142dup	BRCA1		not provided	VCV001239650	17	41219853 - 41219854	17	43067836 - 43067837	1239650	1228773	rs11421283	NC_000017.11:43067836:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Aug 12, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-195_4987-194insTT	BRCA1		not provided	VCV001327189	17	41219906 - 41219907	17	43067889 - 43067890	1327189	1317703	rs1445686894	NC_000017.11:43067889::AA	Insertion	intron variant	Benign	Dec 1, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-197_4987-196dup	BRCA1		not provided	VCV001287895	17	41219907 - 41219908	17	43067890 - 43067891	1287895	1277727	rs71157702	NC_000017.11:43067890:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 15, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-196dup	BRCA1		not provided	VCV001257080	17	41219907 - 41219908	17	43067890 - 43067891	1257080	1246577	rs71157702	NC_000017.11:43067890:AAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 19, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4987-511T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209350	17	41220223	17	43068206	209350	206308	rs8176231	NC_000017.11:43068205:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-576G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209351	17	41220288	17	43068271	209351	206309	rs8176229	NC_000017.11:43068270:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-608G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209352	17	41220320	17	43068303	209352	206310	rs8176228	NC_000017.11:43068302:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-1060G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209353	17	41220772	17	43068755	209353	206311	rs145869415	NC_000017.11:43068754:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4987-1466G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209354	17	41221178	17	43069161	209354	206312	rs8176226	NC_000017.11:43069160:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4986+1349G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209355	17	41221596	17	43069579	209355	206313	rs8176225	NC_000017.11:43069578:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4986+846G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209356	17	41222099	17	43070082	209356	206314	rs8176222	NC_000017.11:43070081:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4986+484A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209357	17	41222461	17	43070444	209357	206315	rs8176221	NC_000017.11:43070443:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4986+483T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209358	17	41222462	17	43070445	209358	206316	rs8176220	NC_000017.11:43070444:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4986+222A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209359	17	41222723	17	43070706	209359	206317	rs3092987	NC_000017.11:43070705:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	BRCA1	F1662S, F558S, F1615S, F1683S, F1621S, F1636S, F1657S, F1659S, F1661S, F469S, F470S, F477S, F512S, F519S, F520S, F532S, F555S, F1366S, F1549S, F1574S, F1592S, F1618S, F1508S, F1550S, F1572S, F1573S, F1591S, F1595S, F1619S, F1643S, F391S, F445S, F446S, F489S, F514S, F516S, F517S, F534S, F581S, F793S, F1365S, F1493S, F1590S, F1593S, F1613S, F1614S, F1642S, F1660S, F1682S, F382S, F431S, F449S, F471S, F479S, F487S, F488S, F492S, F510S, F518S, F533S, F557S, F1533S, F1534S, F1535S, F1551S, F1620S, F1634S, F1635S, F1658S, F1684S, F432S, F450S, F491S, F511S, F556S, F559S, F580S, F794S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055339	17	41222946	17	43070929	55339	70006	rs28897695	NC_000017.11:43070928:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	BRCA1	M1652I, M548I, M1673I, M1605I, M1523I, M1582I, M1604I, M1611I, M1633I, M1649I, M459I, M460I, M467I, M477I, M502I, M504I, M510I, M546I, M1356I, M1563I, M1564I, M1580I, M1585I, M1483I, M1524I, M1525I, M1608I, M1632I, M1647I, M1672I, M372I, M421I, M461I, M482I, M500I, M507I, M524I, M545I, M549I, M1355I, M1498I, M1539I, M1540I, M1581I, M1583I, M1603I, M1624I, M1648I, M1650I, M1651I, M1674I, M439I, M440I, M481I, M501I, M506I, M522I, M547I, M570I, M783I, M1541I, M1562I, M1609I, M1610I, M1626I, M381I, M422I, M435I, M436I, M469I, M478I, M479I, M508I, M509I, M523I, M571I, M784I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041830	17	41222975	17	43070958	41830	50269	rs1799967	NC_000017.11:43070957:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4955T>C (p.Met1652Thr)	BRCA1	M1652T, M1673T, M1605T, M548T, M1539T, M1583T, M1585T, M1603T, M1625T, M1626T, M1647T, M1650T, M1651T, M381T, M421T, M459T, M461T, M469T, M478T, M504T, M506T, M508T, M545T, M549T, M571T, M1356T, M1563T, M1611T, M1624T, M1632T, M1633T, M1649T, M439T, M440T, M467T, M501T, M510T, M522T, M523T, M1483T, M1498T, M1524T, M1525T, M1541T, M1562T, M1564T, M1580T, M1582T, M1608T, M1609T, M1674T, M422T, M435T, M436T, M460T, M477T, M481T, M500T, M502T, M509T, M783T, M1355T, M1523T, M1540T, M1581T, M1604T, M1610T, M1648T, M1672T, M372T, M479T, M482T, M507T, M524T, M546T, M547T, M570T, M784T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037615	17	41222976	17	43070959	37615	46171	rs80356968	NC_000017.11:43070958:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4941C>G (p.Asn1647Lys)	BRCA1	N1600K, N1647K, N543K, N1668K, N1493K, N1557K, N1558K, N1577K, N1578K, N1580K, N1603K, N1606K, N1619K, N1620K, N1628K, N1644K, N435K, N497K, N503K, N504K, N505K, N542K, N566K, N779K, N1350K, N1520K, N1535K, N1559K, N1621K, N1642K, N1645K, N1669K, N416K, N430K, N455K, N456K, N462K, N474K, N477K, N495K, N496K, N501K, N517K, N540K, N544K, N565K, N1518K, N1519K, N1534K, N1536K, N1575K, N1604K, N1605K, N1627K, N1667K, N367K, N434K, N472K, N499K, N502K, N519K, N1351K, N1478K, N1576K, N1598K, N1599K, N1643K, N1646K, N376K, N417K, N431K, N454K, N464K, N473K, N476K, N518K, N541K, N778K	Hereditary cancer-predisposing syndrome	VCV000865710	17	41222990	17	43070973	865710	854304	rs80357302	NC_000017.11:43070972:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Dec 24, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4923T>C (p.Ala1641=)	BRCA1		Hereditary cancer-predisposing syndrome	VCV000868413	17	41223008	17	43070991	868413	854348	rs876658258	NC_000017.11:43070990:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Aug 19, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4913A>T (p.Glu1638Val)	BRCA1	E1591V, E1638V, E1659V, E534V, E1526V, E1527V, E1549V, E1589V, E1595V, E1637V, E1658V, E1660V, E358V, E425V, E467V, E487V, E488V, E494V, E496V, E535V, E1341V, E1469V, E1484V, E1548V, E1550V, E1566V, E1569V, E1571V, E1634V, E407V, E447V, E463V, E492V, E508V, E532V, E557V, E1342V, E1509V, E1510V, E1511V, E1525V, E1567V, E1610V, E1611V, E1612V, E1619V, E1635V, E367V, E426V, E455V, E464V, E468V, E486V, E493V, E510V, E556V, E769V, E1568V, E1590V, E1594V, E1596V, E1597V, E1618V, E1633V, E1636V, E408V, E421V, E422V, E445V, E446V, E453V, E465V, E490V, E495V, E509V, E531V, E533V, E770V	not specified	VCV000868843	17	41223018	17	43071001	868843	854370	rs2052380495	NC_000017.11:43071000:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	BRCA1	P1637L, P1590L, P533L, P1658L, P1526L, P1547L, P1570L, P1595L, P1596L, P1632L, P1659L, P421L, P452L, P486L, P489L, P493L, P494L, P508L, P556L, P1341L, P1510L, P1524L, P1549L, P1566L, P1568L, P1609L, P1617L, P1636L, P366L, P406L, P425L, P463L, P464L, P466L, P485L, P495L, P507L, P1468L, P1525L, P1548L, P1567L, P1588L, P1593L, P1610L, P1634L, P1635L, P357L, P446L, P487L, P492L, P531L, P1340L, P1483L, P1508L, P1509L, P1565L, P1589L, P1594L, P1611L, P1618L, P1633L, P1657L, P407L, P420L, P424L, P444L, P445L, P454L, P462L, P467L, P491L, P532L, P534L, P509L, P530L, P555L, P768L, P769L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055314	17	41223021	17	43071004	55314	69981	rs80357048	NC_000017.11:43071003:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4883T>C (p.Met1628Thr)	BRCA1	M1628T, M1649T, M524T, M1581T, M485T, M498T, M1501T, M1539T, M1558T, M1584T, M1600T, M1601T, M1602T, M1623T, M1648T, M397T, M411T, M435T, M458T, M476T, M477T, M1332T, M1517T, M1538T, M1540T, M1557T, M1561T, M1608T, M1609T, M348T, M357T, M412T, M416T, M437T, M453T, M454T, M455T, M478T, M482T, M499T, M523T, M525T, M760T, M1459T, M1474T, M1515T, M1579T, M1585T, M1586T, M1625T, M415T, M436T, M443T, M445T, M483T, M484T, M486T, M500T, M521T, M547T, M1331T, M1499T, M1500T, M1516T, M1556T, M1559T, M1580T, M1587T, M1624T, M1626T, M1627T, M1650T, M398T, M457T, M480T, M522T, M546T, M759T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041828	17	41223048	17	43071031	41828	50267	rs4986854	NC_000017.11:43071030:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	BRCA1	P1614S, P1635S, P1567S, P510S, P1318S, P1460S, P1524S, P1526S, P1543S, P1544S, P1573S, P1609S, P1612S, P1613S, P1636S, P401S, P421S, P423S, P470S, P472S, P508S, P1501S, P1525S, P1542S, P1547S, P1565S, P1571S, P1572S, P1587S, P1588S, P1595S, P1610S, P343S, P429S, P471S, P484S, P486S, P509S, P511S, P746S, P1485S, P1486S, P1503S, P1586S, P1594S, P1634S, P383S, P384S, P397S, P422S, P431S, P439S, P441S, P443S, P464S, P469S, P485S, P507S, P532S, P533S, P745S, P1317S, P1445S, P1487S, P1502S, P1545S, P1566S, P1570S, P1611S, P334S, P398S, P402S, P440S, P444S, P462S, P463S, P466S, P468S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055301	17	41223091	17	43071074	55301	69968	rs70953660	NC_000017.11:43071073:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	S1613G, S1634G, S509G, S1566G, S1486G, S1524G, S1542G, S1543G, S1544G, S1633G, S382G, S383G, S397G, S421G, S428G, S442G, S461G, S468G, S744G, S1317G, S1541G, S1565G, S1572G, S1585G, S1593G, S1610G, S1612G, S422G, S430G, S439G, S462G, S463G, S469G, S471G, S483G, S507G, S532G, S1459G, S1500G, S1501G, S1502G, S1525G, S1546G, S1569G, S1571G, S1586G, S1587G, S1609G, S1635G, S333G, S342G, S400G, S438G, S465G, S484G, S485G, S506G, S510G, S1316G, S1444G, S1484G, S1485G, S1523G, S1564G, S1570G, S1594G, S1608G, S1611G, S396G, S401G, S420G, S440G, S443G, S467G, S470G, S508G, S531G, S745G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041827	17	41223094	17	43071077	41827	50266	rs1799966	NC_000017.11:43071076:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4837A>T (p.Ser1613Cys)	BRCA1	S1613C, S1634C, S509C, S1566C, S1486C, S1502C, S1524C, S1541C, S1544C, S1569C, S1570C, S1608C, S1611C, S1633C, S1635C, S401C, S443C, S471C, S483C, S484C, S1459C, S1484C, S1485C, S1543C, S1572C, S1586C, S342C, S382C, S396C, S420C, S421C, S422C, S430C, S438C, S440C, S463C, S467C, S745C, S1316C, S1501C, S1525C, S1565C, S1571C, S1594C, S1612C, S333C, S397C, S400C, S428C, S439C, S465C, S468C, S485C, S508C, S510C, S531C, S532C, S744C, S1317C, S1444C, S1500C, S1523C, S1542C, S1546C, S1564C, S1585C, S1587C, S1593C, S1609C, S1610C, S383C, S442C, S461C, S462C, S469C, S470C, S506C, S507C	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037613	17	41223094	17	43071077	37613	46169	rs1799966	NC_000017.11:43071076:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	BRCA1	K1606E, K502E, K1627E, K1559E, K1452E, K1493E, K1495E, K1516E, K1534E, K1557E, K1563E, K1586E, K1601E, K1602E, K1603E, K1605E, K390E, K421E, K436E, K454E, K477E, K524E, K525E, K737E, K1310E, K1437E, K1477E, K1478E, K1518E, K1539E, K1579E, K1587E, K1628E, K376E, K389E, K393E, K460E, K463E, K464E, K499E, K500E, K1309E, K1479E, K1494E, K1535E, K1536E, K1537E, K1564E, K1578E, K326E, K375E, K413E, K415E, K431E, K433E, K455E, K456E, K462E, K478E, K738E, K1517E, K1558E, K1562E, K1565E, K1580E, K1604E, K1626E, K335E, K394E, K414E, K423E, K432E, K435E, K458E, K461E, K476E, K501E, K503E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037612	17	41223115	17	43071098	37612	46168	rs80356943	NC_000017.11:43071097:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4812A>G (p.Gln1604=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055293	17	41223119	17	43071102	55293	69960	rs28897693	NC_000017.11:43071101:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.4729T>C (p.Ser1577Pro)	BRCA1	S1577P, S473P, S1530P, S1598P, S1408P, S1466P, S1505P, S1529P, S1535P, S1549P, S1557P, S1558P, S1575P, S1576P, S347P, S360P, S365P, S406P, S407P, S425P, S447P, S1280P, S1487P, S1528P, S1534P, S1574P, S1597P, S361P, S392P, S403P, S426P, S429P, S435P, S449P, S495P, S1423P, S1450P, S1465P, S1488P, S1508P, S1510P, S1533P, S1536P, S1550P, S1572P, S1573P, S346P, S394P, S402P, S427P, S431P, S432P, S434P, S448P, S471P, S472P, S496P, S1281P, S1448P, S1449P, S1464P, S1489P, S1506P, S1507P, S1551P, S1599P, S297P, S306P, S364P, S384P, S385P, S386P, S404P, S433P, S470P, S474P, S708P, S709P	Hereditary cancer-predisposing syndrome|not specified|Fanconi anemia, complementation group S|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055272	17	41223202	17	43071185	55272	69939	rs80356909	NC_000017.11:43071184:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	BRCA1	L1564P, L1585P, L1517P, L460P, L1435P, L1453P, L1492P, L1493P, L1494P, L1497P, L1516P, L1521P, L1560P, L1562P, L1586P, L347P, L351P, L391P, L393P, L412P, L482P, L1410P, L1436P, L1437P, L1452P, L1474P, L1476P, L1515P, L1520P, L1538P, L1544P, L1545P, L1561P, L1584P, L333P, L348P, L373P, L381P, L394P, L420P, L422P, L436P, L461P, L695P, L1267P, L1268P, L1495P, L1536P, L1537P, L284P, L352P, L371P, L379P, L390P, L416P, L418P, L421P, L457P, L458P, L483P, L696P, L1395P, L1451P, L1475P, L1522P, L1523P, L1559P, L1563P, L293P, L334P, L372P, L389P, L413P, L414P, L419P, L434P, L435P, L459P	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055262	17	41223240	17	43071223	55262	69929	rs56119278	NC_000017.11:43071222:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4682C>T (p.Thr1561Ile)	BRCA1	T1561I, T1582I, T457I, T1514I, T411I, T419I, T433I, T455I, T1265I, T1392I, T1407I, T1448I, T1449I, T1450I, T1471I, T1473I, T1494I, T1517I, T1533I, T331I, T368I, T387I, T391I, T413I, T416I, T417I, T432I, T480I, T692I, T1433I, T1489I, T1490I, T1513I, T1520I, T1535I, T1542I, T1558I, T344I, T370I, T376I, T388I, T1434I, T1472I, T1491I, T1492I, T1512I, T1534I, T1541I, T1556I, T1559I, T290I, T345I, T349I, T378I, T386I, T409I, T410I, T415I, T1264I, T1432I, T1518I, T1519I, T1557I, T1560I, T1581I, T1583I, T281I, T330I, T348I, T369I, T390I, T418I, T431I, T454I, T456I, T458I, T479I, T693I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|not provided|BRCA1-related cancer predisposition|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast	VCV000055259	17	41223249	17	43071232	55259	69926	rs56158747	NC_000017.11:43071231:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4676-7C>T	BRCA1		Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037606	17	41223262	17	43071245	37606	46162	rs80358005	NC_000017.11:43071244:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4676-8C>G	BRCA1		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided	VCV000125727	17	41223263	17	43071246	125727	131265	rs80358021	NC_000017.11:43071245:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4676-16C>G	BRCA1		not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091634	17	41223271	17	43071254	91634	97111	rs80358067	NC_000017.11:43071253:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4676-55C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264790	17	41223310	17	43071293	264790	259557	rs545107728	NC_000017.11:43071292:G:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4676-284_4676-283insATTACAAGCATTGTTACAGTGAAC	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264795	17	41223538 - 41223539	17	43071521 - 43071522	264795	259558	rs8176218	NC_000017.11:43071521:AAT:AATGTTCACTGTAACAATGCTTGTAAT	Insertion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4676-777del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209360	17	41224032	17	43072015	209360	206318	rs200424092	NC_000017.11:43072014:T:	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4676-1011G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209361	17	41224266	17	43072249	209361	206319	rs183687995	NC_000017.11:43072248:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4676-1025G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209362	17	41224280	17	43072263	209362	206320	rs138082324	NC_000017.11:43072262:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+1515C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209363	17	41224833	17	43072816	209363	206321	rs111499627	NC_000017.11:43072815:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+1455dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264848	17	41224892 - 41224893	17	43072875 - 43072876	264848	259559	rs533819030	NC_000017.11:43072875:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+1392T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264784	17	41224956	17	43072939	264784	259560	rs191530878	NC_000017.11:43072938:A:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+903C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209364	17	41225445	17	43073428	209364	206322	rs74877299	NC_000017.11:43073427:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+693del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209365	17	41225655	17	43073638	209365	206323	rs5820482	NC_000017.11:43073637:AAAAAAAA:AAAAAAA	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+581T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209366	17	41225767	17	43073750	209366	206324	rs8176217	NC_000017.11:43073749:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+569T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209367	17	41225779	17	43073762	209367	206325	rs182629224	NC_000017.11:43073761:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+567T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209368	17	41225781	17	43073764	209368	206326	rs8176216	NC_000017.11:43073763:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+565T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209369	17	41225783	17	43073766	209369	206327	rs8176215	NC_000017.11:43073765:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+563A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209370	17	41225785	17	43073768	209370	206328	rs190123841	NC_000017.11:43073767:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+509A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209371	17	41225839	17	43073822	209371	206329	rs8176214	NC_000017.11:43073821:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+315A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209372	17	41226033	17	43074016	209372	206330	rs2236763	NC_000017.11:43074015:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+105G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209373	17	41226243	17	43074226	209373	206331	rs8176213	NC_000017.11:43074225:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4675+55A>G	BRCA1		not specified	VCV001686624	17	41226293	17	43074276	1686624	1678629	rs934064952	NC_000017.11:43074275:T:C	single nucleotide variant	intron variant	Benign	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4636G>T (p.Asp1546Tyr)	BRCA1	D1546Y, D1567Y, D442Y, D1499Y, D1249Y, D1377Y, D1435Y, D1458Y, D1503Y, D1520Y, D1541Y, D1543Y, D1545Y, D1568Y, D333Y, D355Y, D376Y, D401Y, D418Y, D441Y, D465Y, D678Y, D1418Y, D1474Y, D1476Y, D1479Y, D1519Y, D1527Y, D1566Y, D275Y, D316Y, D330Y, D353Y, D354Y, D371Y, D372Y, D395Y, D396Y, D402Y, D404Y, D440Y, D1250Y, D1417Y, D1434Y, D1475Y, D1477Y, D1498Y, D1502Y, D1504Y, D1518Y, D1526Y, D1542Y, D1544Y, D361Y, D363Y, D373Y, D375Y, D394Y, D403Y, D417Y, D443Y, D1419Y, D1433Y, D1456Y, D1457Y, D1497Y, D1505Y, D315Y, D329Y, D334Y, D398Y, D400Y, D416Y, D439Y, D464Y, D677Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055246	17	41226387	17	43074370	55246	69913	rs28897691	NC_000017.11:43074369:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4636G>A (p.Asp1546Asn)	BRCA1	D1546N, D1567N, D442N, D1499N, D1250N, D1417N, D1433N, D1498N, D1520N, D1542N, D1545N, D1566N, D1568N, D329N, D353N, D363N, D403N, D417N, D678N, D1457N, D1474N, D1502N, D1504N, D1526N, D1527N, D1541N, D315N, D334N, D361N, D372N, D394N, D396N, D401N, D439N, D464N, D1418N, D1435N, D1475N, D1476N, D1479N, D1518N, D1544N, D316N, D330N, D333N, D355N, D371N, D375N, D404N, D418N, D465N, D1249N, D1377N, D1419N, D1434N, D1456N, D1458N, D1477N, D1497N, D1503N, D1505N, D1519N, D1543N, D275N, D354N, D373N, D376N, D395N, D398N, D400N, D402N, D416N, D440N, D441N, D443N, D677N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055245	17	41226387	17	43074370	55245	69912	rs28897691	NC_000017.11:43074369:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4600G>A (p.Val1534Met)	BRCA1	V1534M, V1555M, V430M, V1487M, V1407M, V1421M, V1422M, V1486M, V1491M, V1506M, V1514M, V1530M, V1554M, V1556M, V383M, V392M, V1444M, V1445M, V1446M, V1464M, V1485M, V1493M, V1508M, V1515M, V1529M, V1531M, V263M, V303M, V321M, V341M, V359M, V361M, V363M, V382M, V388M, V389M, V391M, V428M, V429M, V666M, V1365M, V1406M, V1423M, V1462M, V1465M, V1467M, V1490M, V1532M, V317M, V349M, V351M, V360M, V364M, V384M, V390M, V406M, V427M, V431M, V452M, V665M, V1237M, V1463M, V1492M, V1507M, V1533M, V304M, V318M, V322M, V342M, V343M, V386M, V404M, V405M, V453M, V1238M, V1405M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055235	17	41226423	17	43074406	55235	69902	rs55815649	NC_000017.11:43074405:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	BRCA1	S1512I, S408I, S1533I, S1465I, S1343I, S1385I, S1441I, S1442I, S1468I, S1492I, S1508I, S1509I, S1510I, S296I, S321I, S361I, S366I, S370I, S383I, S409I, S644I, S1215I, S1422I, S1423I, S1440I, S1445I, S1463I, S1464I, S1471I, S1493I, S1507I, S241I, S282I, S327I, S329I, S337I, S341I, S342I, S362I, S367I, S384I, S407I, S430I, S1383I, S1400I, S1401I, S1443I, S1469I, S1484I, S1485I, S1486I, S1511I, S1534I, S281I, S299I, S338I, S364I, S369I, S382I, S405I, S406I, S431I, S1216I, S1384I, S1399I, S1424I, S1470I, S1532I, S295I, S300I, S319I, S320I, S339I, S360I, S368I, S643I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041826	17	41226488	17	43074471	41826	50265	rs1800744	NC_000017.11:43074470:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4527C>T (p.Tyr1509=)	BRCA1		not provided|BRCA1-related cancer predisposition|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000633098	17	41226496	17	43074479	633098	621573	rs886040233	NC_000017.11:43074478:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4520G>C (p.Arg1507Thr)	BRCA1	R1507T, R1460T, R1528T, R403T, R1418T, R1437T, R1458T, R1459T, R1464T, R1465T, R1479T, R1487T, R1488T, R1504T, R1506T, R277T, R315T, R332T, R333T, R355T, R356T, R378T, R379T, R426T, R1210T, R1338T, R1379T, R1380T, R1395T, R1436T, R1466T, R1480T, R1503T, R1529T, R236T, R314T, R324T, R334T, R361T, R362T, R400T, R404T, R425T, R638T, R639T, R1378T, R1419T, R1438T, R1440T, R1463T, R1502T, R1505T, R1527T, R290T, R316T, R322T, R337T, R357T, R363T, R377T, R401T, R402T, R1211T, R1394T, R1396T, R1417T, R1435T, R1481T, R276T, R291T, R294T, R295T, R336T, R359T, R364T, R365T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041825	17	41226503	17	43074486	41825	50264	rs80357470	NC_000017.11:43074485:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-63C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209374	17	41226601	17	43074584	209374	206332	rs273900734	NC_000017.11:43074583:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-137T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209375	17	41226675	17	43074658	209375	206333	rs2236762	NC_000017.11:43074657:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-203_4485-199del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209376	17	41226737 - 41226741	17	43074720 - 43074724	209376	206334	rs34250703	NC_000017.11:43074719:GGGTTGGGTTGG:GGGTTGG	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-340G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209377	17	41226878	17	43074861	209377	206335	rs8176209	NC_000017.11:43074860:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-413_4485-400del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264821	17	41226938 - 41226951	17	43074921 - 43074934	264821	259561	rs566416929	NC_000017.11:43074920:GAAAGAAAGGAAAGGAAAGAAAGGAAAG:GAAAGAAAGGAAAG	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4485-565TTCC[6]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209378	17	41227083 - 41227084	17	43075066 - 43075067	209378	206336	rs8176207	NC_000017.11:43075066:GGAAGGAAGGAAGGAAGGAA:GGAAGGAAGGAAGGAAGGAAGGAA	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484+899C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209379	17	41227606	17	43075589	209379	206337	rs181392764	NC_000017.11:43075588:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484+463C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209380	17	41228042	17	43076025	209380	206338	rs56295923	NC_000017.11:43076024:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484+385A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209381	17	41228120	17	43076103	209381	206339	rs8176206	NC_000017.11:43076102:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4484+39A>G	BRCA1		not specified	VCV001697603	17	41228466	17	43076449	1697603	1689987	rs371380546	NC_000017.11:43076448:T:C	single nucleotide variant	intron variant	Benign	Mar 4, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4484+14A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055210	17	41228491	17	43076474	55210	69877	rs80358022	NC_000017.11:43076473:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4402A>C (p.Asn1468His)	BRCA1	N1468H, N1421H, N1489H, N364H, N1299H, N1355H, N1357H, N1396H, N1398H, N1420H, N1425H, N1440H, N238H, N251H, N275H, N297H, N298H, N317H, N339H, N1339H, N1340H, N1378H, N1380H, N1397H, N1399H, N1401H, N1426H, N1427H, N1449H, N237H, N276H, N294H, N322H, N323H, N326H, N338H, N362H, N365H, N387H, N600H, N1171H, N1379H, N1419H, N1441H, N1448H, N1463H, N1467H, N1490H, N197H, N255H, N277H, N285H, N293H, N295H, N320H, N340H, N361H, N599H, N1172H, N1341H, N1356H, N1424H, N1442H, N1464H, N1465H, N1466H, N1488H, N252H, N256H, N283H, N316H, N318H, N324H, N325H, N363H, N386H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055193	17	41228587	17	43076570	55193	69860	rs80357022	NC_000017.11:43076569:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-10C>T	BRCA1		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125710	17	41228641	17	43076624	125710	131248	rs80358111	NC_000017.11:43076623:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4358-722dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264802	17	41229352 - 41229353	17	43077335 - 43077336	264802	259562	rs68171917	NC_000017.11:43077335:TTTTTTTTTTTTT:TTTTTTTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-755A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209382	17	41229386	17	43077369	209382	206340	rs12940378	NC_000017.11:43077368:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1130del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209383	17	41229761	17	43077744	209383	206341	rs8176205	NC_000017.11:43077743:TTTTTTTT:TTTTTTT	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1132A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264793	17	41229763	17	43077746	264793	259563	rs8176204	NC_000017.11:43077745:T:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1142A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264844	17	41229773	17	43077756	264844	259564	rs8176203	NC_000017.11:43077755:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1147dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209384	17	41229777 - 41229778	17	43077760 - 43077761	209384	206342	rs11368665	NC_000017.11:43077760:TTT:TTTT	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1181T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209385	17	41229812	17	43077795	209385	206343	rs4239147	NC_000017.11:43077794:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1194T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264814	17	41229825	17	43077808	264814	259565	rs182653629	NC_000017.11:43077807:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1226C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209386	17	41229857	17	43077840	209386	206344	rs4239148	NC_000017.11:43077839:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1277A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209387	17	41229908	17	43077891	209387	206345	rs4318274	NC_000017.11:43077890:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1413C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209388	17	41230044	17	43078027	209388	206346	rs117089582	NC_000017.11:43078026:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1475del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264827	17	41230106	17	43078089	264827	259566	rs35184764	NC_000017.11:43078088:TTTTTTTTTTTTTT:TTTTTTTTTTTTT	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1597C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209389	17	41230228	17	43078211	209389	206347	rs8176202	NC_000017.11:43078210:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1705T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209390	17	41230336	17	43078319	209390	206348	rs8176201	NC_000017.11:43078318:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1745T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209391	17	41230376	17	43078359	209391	206349	rs8176200	NC_000017.11:43078358:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1893A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209392	17	41230524	17	43078507	209392	206350	rs8176199	NC_000017.11:43078506:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-1906T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209393	17	41230537	17	43078520	209393	206351	rs8176198	NC_000017.11:43078519:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2324C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209394	17	41230955	17	43078938	209394	206352	rs111819895	NC_000017.11:43078937:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2351G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209395	17	41230982	17	43078965	209395	206353	rs8176197	NC_000017.11:43078964:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2359T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209396	17	41230990	17	43078973	209396	206354	rs8176196	NC_000017.11:43078972:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2455C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209397	17	41231086	17	43079069	209397	206355	rs147065412	NC_000017.11:43079068:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2590T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209398	17	41231221	17	43079204	209398	206356	rs8176194	NC_000017.11:43079203:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2704C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136548	17	41231335	17	43079318	136548	140251	rs562625234	NC_000017.11:43079317:G:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4358-2885G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209399	17	41231516	17	43079499	209399	206357	rs8176193	NC_000017.11:43079498:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+2723C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209400	17	41231698	17	43079681	209400	206358	rs8176192	NC_000017.11:43079680:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+2615dup	BRCA1		not provided	VCV001220789	17	41231805 - 41231806	17	43079788 - 43079789	1220789	1212476	rs56914599	NC_000017.11:43079788:AAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 13, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4357+2519C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209401	17	41231902	17	43079885	209401	206359	rs4793197	NC_000017.11:43079884:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+2313T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264782	17	41232108	17	43080091	264782	259567	rs149328571	NC_000017.11:43080090:A:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+2128T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209402	17	41232293	17	43080276	209402	206360	rs77008361	NC_000017.11:43080275:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+2077C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209929	17	41232344	17	43080327	209929	206361	rs6416927	NC_000017.11:43080326:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+2045G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209403	17	41232376	17	43080359	209403	206362	rs143578208	NC_000017.11:43080358:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+1723G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209404	17	41232698	17	43080681	209404	206363	rs8176190	NC_000017.11:43080680:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+1563T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209405	17	41232858	17	43080841	209405	206364	rs8176188	NC_000017.11:43080840:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+1513dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209406	17	41232907 - 41232908	17	43080890 - 43080891	209406	206365	rs200147389	NC_000017.11:43080890:AAAAAAAAAA:AAAAAAAAAAA	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+1386T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209407	17	41233035	17	43081018	209407	206366	rs77473713	NC_000017.11:43081017:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+1212T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209408	17	41233209	17	43081192	209408	206367	rs8176187	NC_000017.11:43081191:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+877C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209409	17	41233544	17	43081527	209409	206368	rs150670602	NC_000017.11:43081526:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+794G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209410	17	41233627	17	43081610	209410	206369	rs8176186	NC_000017.11:43081609:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+651A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264818	17	41233770	17	43081753	264818	259568	rs530463308	NC_000017.11:43081752:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+380A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209411	17	41234041	17	43082024	209411	206370	rs8176185	NC_000017.11:43082023:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+259A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264849	17	41234162	17	43082145	264849	259569	rs543852008	NC_000017.11:43082144:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+117G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125708	17	41234304	17	43082287	125708	131246	rs3737559	NC_000017.11:43082286:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4357+17A>G	BRCA1		Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000125709	17	41234404	17	43082387	125709	131247	rs80358180	NC_000017.11:43082386:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4327C>G (p.Arg1443Gly)	BRCA1	R1443G, R340G, R1396G, R1353G, R1372G, R1395G, R1415G, R1416G, R213G, R229G, R259G, R272G, R299G, R574G, R1315G, R1332G, R1373G, R1375G, R1394G, R1400G, R1402G, R1439G, R212G, R251G, R269G, R270G, R300G, R313G, R338G, R1316G, R1330G, R1331G, R1417G, R1442G, R227G, R252G, R293G, R314G, R339G, R575G, R1147G, R1274G, R1354G, R1355G, R1371G, R1376G, R1401G, R1441G, R172G, R230G, R231G, R260G, R273G, R291G, R292G, R295G, R298G, R301G, R337G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017676	17	41234451	17	43082434	17676	32715	rs41293455	NC_000017.11:43082433:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4308T>A (p.Ser1436=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000755101	17	41234470	17	43082453	755101	771532	rs1060915	NC_000017.11:43082452:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4308T>C (p.Ser1436=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125703	17	41234470	17	43082453	125703	131241	rs1060915	NC_000017.11:43082452:A:G	single nucleotide variant	synonymous variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4255G>C (p.Glu1419Gln)	BRCA1	E1419Q, E316Q, E1372Q, E1329Q, E1347Q, E1378Q, E206Q, E228Q, E235Q, E267Q, E315Q, E550Q, E1123Q, E1291Q, E1306Q, E1308Q, E1348Q, E1349Q, E1377Q, E1391Q, E1392Q, E189Q, E205Q, E248Q, E249Q, E271Q, E276Q, E290Q, E313Q, E314Q, E1307Q, E1330Q, E1370Q, E1418Q, E148Q, E236Q, E245Q, E277Q, E551Q, E1250Q, E1292Q, E1331Q, E1351Q, E1352Q, E1371Q, E1376Q, E1393Q, E1415Q, E1417Q, E188Q, E203Q, E207Q, E227Q, E246Q, E268Q, E269Q, E274Q, E275Q, E289Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055154	17	41234523	17	43082506	55154	69821	rs80357309	NC_000017.11:43082505:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	BRCA1	H1402Y, H299Y, H1355Y, H1233Y, H1275Y, H1289Y, H1312Y, H1314Y, H1330Y, H1334Y, H1335Y, H257Y, H260Y, H298Y, H1291Y, H1331Y, H1353Y, H1361Y, H1374Y, H1376Y, H171Y, H186Y, H190Y, H210Y, H211Y, H218Y, H232Y, H250Y, H251Y, H297Y, H533Y, H1106Y, H1290Y, H1313Y, H131Y, H1375Y, H1398Y, H1400Y, H172Y, H189Y, H219Y, H228Y, H229Y, H252Y, H254Y, H259Y, H272Y, H1274Y, H1332Y, H1354Y, H1359Y, H1360Y, H1401Y, H188Y, H231Y, H258Y, H273Y, H296Y, H534Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055140	17	41234574	17	43082557	55140	69807	rs80357365	NC_000017.11:43082556:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-5dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002009078	17	41234596 - 41234597	17	43082579 - 43082580	2009078	2063150	rs2154164994	NC_000017.11:43082579:AAAAA:AAAAAA	Duplication	intron variant	Benign	Aug 16, 2023	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4186-514T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209412	17	41235106	17	43083089	209412	206371	rs75754723	NC_000017.11:43083088:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-603GAAA[5]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264774	17	41235179 - 41235180	17	43083162 - 43083163	264774	259570	rs527906133	NC_000017.11:43083162:TTTCTTTCTTTCTTTCTTT:TTTCTTTCTTTCTTTCTTTCTTT	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-1207C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209413	17	41235799	17	43083782	209413	206372	rs8067269	NC_000017.11:43083781:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-1247A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209414	17	41235839	17	43083822	209414	206373	rs8176182	NC_000017.11:43083821:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-1451C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209415	17	41236043	17	43084026	209415	206374	rs8176181	NC_000017.11:43084025:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-1457del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264801	17	41236049	17	43084032	264801	259571	rs571319167	NC_000017.11:43084031:TTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-2050A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209416	17	41236642	17	43084625	209416	206375	rs8176178	NC_000017.11:43084624:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-2187C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264853	17	41236779	17	43084762	264853	259572	rs562679568	NC_000017.11:43084761:G:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-2483A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209417	17	41237075	17	43085058	209417	206376	rs8176177	NC_000017.11:43085057:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-2852T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209418	17	41237444	17	43085427	209418	206377	rs8176176	NC_000017.11:43085426:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-3102dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209419	17	41237693 - 41237694	17	43085676 - 43085677	209419	206378	rs8176175	NC_000017.11:43085676:AA:AAA	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-3361C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209420	17	41237953	17	43085936	209420	206379	rs3950989	NC_000017.11:43085935:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-3420A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209421	17	41238012	17	43085995	209421	206380	rs8176174	NC_000017.11:43085994:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-3572GT[22]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264775	17	41238126 - 41238127	17	43086109 - 43086110	264775	259573	rs376686434	NC_000017.11:43086109:ACACACACACACACACACACACACACACACACACACACA:ACACACACACACACACACACACACACACACACACACACACACACA	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-3910T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209422	17	41238502	17	43086485	209422	206381	rs151196052	NC_000017.11:43086484:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4186-4027G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209423	17	41238619	17	43086602	209423	206382	rs8176173	NC_000017.11:43086601:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+3489C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209424	17	41239472	17	43087455	209424	206383	rs8176171	NC_000017.11:43087454:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+3470A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209425	17	41239491	17	43087474	209425	206384	rs8176170	NC_000017.11:43087473:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+3334G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264807	17	41239627	17	43087610	264807	259574	rs8176169	NC_000017.11:43087609:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+3333T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209426	17	41239628	17	43087611	209426	206385	rs8176168	NC_000017.11:43087610:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+3045del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264847	17	41239916	17	43087899	264847	259575	rs144110800	NC_000017.11:43087898:TTTTTTTTTTTTT:TTTTTTTTTTTT	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+3033A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264855	17	41239928	17	43087911	264855	259576	rs79996471	NC_000017.11:43087910:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+2981A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264826	17	41239980	17	43087963	264826	259577	rs8176167	NC_000017.11:43087962:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+2684A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209427	17	41240277	17	43088260	209427	206386	rs8176166	NC_000017.11:43088259:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+2361G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209428	17	41240600	17	43088583	209428	206387	rs147509580	NC_000017.11:43088582:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+2211C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209429	17	41240750	17	43088733	209429	206388	rs8176165	NC_000017.11:43088732:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+2046T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209430	17	41240915	17	43088898	209430	206389	rs8176163	NC_000017.11:43088897:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+1787T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209431	17	41241174	17	43089157	209431	206390	rs8176162	NC_000017.11:43089156:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+1571G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209432	17	41241390	17	43089373	209432	206391	rs8176161	NC_000017.11:43089372:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+1458A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209433	17	41241503	17	43089486	209433	206392	rs8176160	NC_000017.11:43089485:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+1393_4185+1394insAG	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209434	17	41241567 - 41241568	17	43089550 - 43089551	209434	206393	rs201979969	NC_000017.11:43089550:T:TCT	Insertion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+1392_4185+1393insG	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209435	17	41241568 - 41241569	17	43089551 - 43089552	209435	206394	rs34293035	NC_000017.11:43089551::C	Insertion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+877CTT[2]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209436	17	41242076 - 41242078	17	43090059 - 43090061	209436	206395	rs200781379	NC_000017.11:43090058:AAGAAGAAGA:AAGAAGA	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+880del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209437	17	41242081	17	43090064	209437	206396	rs200098203	NC_000017.11:43090063:G:	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+879del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209438	17	41242082	17	43090065	209438	206397	rs77684117	NC_000017.11:43090064:AA:A	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+676A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209439	17	41242285	17	43090268	209439	206398	rs2070834	NC_000017.11:43090267:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+563A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209440	17	41242398	17	43090381	209440	206399	rs8176155	NC_000017.11:43090380:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+355C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209441	17	41242606	17	43090589	209441	206400	rs148953585	NC_000017.11:43090588:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+201_4185+206dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264806	17	41242754 - 41242755	17	43090737 - 43090738	264806	259578	rs138544133	NC_000017.11:43090737:GTGCGCGTG:GTGCGCGTGCGCGTG	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+112C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209443	17	41242849	17	43090832	209443	206402	rs2070833	NC_000017.11:43090831:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+11TG[5]	BRCA1		not specified|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome	VCV000125686	17	41242939 - 41242940	17	43090922 - 43090923	125686	131224	rs273900723	NC_000017.11:43090921:CACACACACACAC:CACACACACAC	Microsatellite	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4185+14G>C	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000188411	17	41242947	17	43090930	188411	186544	rs762153716	NC_000017.11:43090929:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4185+10G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125685	17	41242951	17	43090934	125685	131223	rs80358104	NC_000017.11:43090933:C:G	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4185+9C>T	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000096929	17	41242952	17	43090935	96929	102832	rs80358034	NC_000017.11:43090934:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4185+7del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002020926	17	41242954	17	43090937	2020926	2076271	rs398122352	NC_000017.11:43090936:TTTTT:TTTT	Deletion	intron variant	Benign	Aug 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	BRCA1	V1378I, V1331I, V275I, V1267I, V1307I, V1310I, V1330I, V1337I, V1351I, V194I, V230I, V236I, V249I, V107I, V1210I, V1250I, V1266I, V1311I, V147I, V164I, V166I, V187I, V205I, V207I, V227I, V233I, V235I, V510I, V1308I, V1336I, V1352I, V163I, V204I, V208I, V228I, V272I, V273I, V274I, V1082I, V1251I, V1289I, V1290I, V1375I, V1377I, V148I, V186I, V195I, V234I, V248I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055111	17	41243014	17	43090997	55111	69778	rs28897690	NC_000017.11:43090996:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4097-11dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001600771	17	41243059 - 41243060	17	43091042 - 43091043	1600771	1546198	rs2154259579	NC_000017.11:43091042:AAAAA:AAAAAA	Duplication	intron variant	Benign	May 17, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-10G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125672	17	41243059	17	43091042	125672	131210	rs80358057	NC_000017.11:43091041:C:T	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4097-11del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001599899	17	41243060	17	43091043	1599899	1662072	rs2154259579	NC_000017.11:43091042:AAAAA:AAAA	Deletion	intron variant	Benign	Jul 4, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-11T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125673	17	41243060	17	43091043	125673	131211	rs80358072	NC_000017.11:43091042:A:G	single nucleotide variant	intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4097-12T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV004071323	17	41243061	17	43091044	4071323	4185171		NC_000017.11:43091043:A:G	single nucleotide variant	intron variant	Benign	Jun 23, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-20C>T	BRCA1		not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000125675	17	41243069	17	43091052	125675	131213	rs80358169	NC_000017.11:43091051:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4097-28A>G	BRCA1		not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225708	17	41243077	17	43091060	225708	227561	rs869320777	NC_000017.11:43091059:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4097-79A>G	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001325659	17	41243128	17	43091111	1325659	1315924	rs2053453145	NC_000017.11:43091110:T:C	single nucleotide variant	intron variant	Benign	Nov 16, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.4097-141A>C	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125674	17	41243190	17	43091173	125674	131212	rs799916	NC_000017.11:43091172:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4096+98_4096+102del	BRCA1|LOC126862571		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	VCV001170582	17	41243350 - 41243354	17	43091333 - 43091337	1170582	1157985	rs750547789	NC_000017.11:43091332:AACTA:	Deletion	intron variant	Benign/Likely benign	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4096+36A>G	BRCA1|LOC126862571		not specified|Hereditary breast ovarian cancer syndrome	VCV001325660	17	41243416	17	43091399	1325660	1315925	rs45620639	NC_000017.11:43091398:T:C	single nucleotide variant	intron variant	Benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4081A>T (p.Met1361Leu)	BRCA1|LOC126862571	M1361L, M1314L, M1233L, M1272L, M1290L, M1313L, M1273L, M1319L, M1335L, M1358L, M1065L, M1250L, M1291L, M1294L, M1334L, M1360L, M1193L, M1234L, M1249L, M1293L, M1320L, M493L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000812551	17	41243467	17	43091450	812551	800791	rs80357218	NC_000017.11:43091449:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.4081A>C (p.Met1361Leu)	LOC126862571|BRCA1	M1361L, M1314L, M1065L, M1233L, M1293L, M1335L, M1234L, M1249L, M1250L, M1273L, M1291L, M1358L, M1360L, M1290L, M1313L, M1334L, M1193L, M1272L, M1294L, M1319L, M1320L, M493L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055099	17	41243467	17	43091450	55099	69766	rs80357218	NC_000017.11:43091449:T:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4046C>T (p.Thr1349Met)	BRCA1|LOC126862571	T1349M, T1302M, T1237M, T1278M, T1301M, T1221M, T1261M, T1279M, T1282M, T1307M, T1322M, T481M, T1053M, T1260M, T1323M, T1348M, T1181M, T1222M, T1238M, T1281M, T1308M, T1346M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055085	17	41243502	17	43091485	55085	69752	rs80357345	NC_000017.11:43091484:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4039A>G (p.Arg1347Gly)	BRCA1|LOC126862571	R1347G, R1300G, R1321G, R1344G, R479G, R1179G, R1220G, R1258G, R1279G, R1299G, R1305G, R1320G, R1051G, R1235G, R1236G, R1259G, R1277G, R1306G, R1346G, R1219G, R1276G, R1280G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041821	17	41243509	17	43091492	41821	50260	rs28897689	NC_000017.11:43091491:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.4036G>A (p.Glu1346Lys)	BRCA1|LOC126862571	E1346K, E1299K, E1050K, E1178K, E1275K, E1276K, E1218K, E1258K, E1305K, E1235K, E1279K, E1298K, E1304K, E1345K, E1219K, E1234K, E1257K, E1278K, E1319K, E1320K, E1343K, E478K	BRCA1-related cancer predisposition|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037561	17	41243512	17	43091495	37561	46117	rs80357407	NC_000017.11:43091494:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.4017A>G (p.Glu1339=)	BRCA1|LOC126862571		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000531502	17	41243531	17	43091514	531502	531257	rs1555586645	NC_000017.11:43091513:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3823A>G (p.Ile1275Val)	BRCA1|LOC126862571	I1275V, I1228V, I1107V, I1147V, I1205V, I1227V, I1233V, I407V, I1164V, I1187V, I1204V, I1208V, I1274V, I1148V, I1207V, I1234V, I1248V, I979V, I1163V, I1186V, I1249V, I1272V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037549	17	41243725	17	43091708	37549	46105	rs80357280	NC_000017.11:43091707:T:C	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3797G>C (p.Ser1266Thr)	BRCA1|LOC126862571	S1266T, S1219T, S1138T, S1178T, S1195T, S1196T, S1224T, S1263T, S398T, S970T, S1139T, S1154T, S1155T, S1225T, S1239T, S1240T, S1098T, S1177T, S1198T, S1218T, S1199T, S1265T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055009	17	41243751	17	43091734	55009	69676	rs80357160	NC_000017.11:43091733:C:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)	BRCA1|LOC126862571	E1250K, E1203K, E1122K, E1182K, E1183K, E1208K, E1249K, E1138K, E1161K, E1162K, E382K, E1082K, E1123K, E1139K, E1179K, E1180K, E1209K, E1223K, E1247K, E1202K, E1224K, E954K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054987	17	41243800	17	43091783	54987	69654	rs28897686	NC_000017.11:43091782:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3747C>A (p.Thr1249=)	BRCA1|LOC126862571		not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000682575	17	41243801	17	43091784	682575	656438	rs587780801	NC_000017.11:43091783:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3739G>A (p.Val1247Ile)	BRCA1|LOC126862571	V1247I, V1200I, V1119I, V1136I, V1179I, V1220I, V1221I, V1158I, V1176I, V1177I, V1180I, V1206I, V1246I, V1079I, V1199I, V1205I, V379I, V1120I, V1135I, V1159I, V1244I, V951I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054985	17	41243809	17	43091792	54985	69652	rs80357191	NC_000017.11:43091791:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3724A>G (p.Thr1242Ala)	BRCA1|LOC126862571	T1242A, T1195A, T1172A, T1174A, T1194A, T1201A, T1215A, T946A, T1074A, T1115A, T1131A, T1171A, T1175A, T1216A, T374A, T1130A, T1153A, T1241A, T1114A, T1154A, T1200A, T1239A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054982	17	41243824	17	43091807	54982	69649	rs80357037	NC_000017.11:43091806:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3713C>T (p.Pro1238Leu)	BRCA1|LOC126862571	P1238L, P1191L, P1070L, P1127L, P1196L, P942L, P1149L, P1171L, P1197L, P1211L, P370L, P1126L, P1150L, P1168L, P1190L, P1110L, P1111L, P1167L, P1170L, P1212L, P1235L, P1237L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037543	17	41243835	17	43091818	37543	46099	rs28897688	NC_000017.11:43091817:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3708T>G (p.Asn1236Lys)	LOC126862571|BRCA1	N1236K, N1189K, N1108K, N1109K, N1125K, N1148K, N1165K, N1209K, N1210K, N1068K, N1168K, N1188K, N1233K, N368K, N940K, N1147K, N1194K, N1195K, N1124K, N1166K, N1169K, N1235K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054970	17	41243840	17	43091823	54970	69637	rs28897687	NC_000017.11:43091822:A:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3684C>T (p.His1228=)	BRCA1|LOC126862571		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000184693	17	41243864	17	43091847	184693	184957	rs786201623	NC_000017.11:43091846:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3657G>T (p.Glu1219Asp)	BRCA1|LOC126862571	E1051D, E1107D, E1192D, E1219D, E351D, E1108D, E1148D, E1151D, E1152D, E1177D, E1178D, E1092D, E1130D, E1149D, E1171D, E1172D, E1193D, E1091D, E1131D, E1216D, E1218D, E923D	Hereditary breast ovarian cancer syndrome	VCV002035518	17	41243891	17	43091874	2035518	2097302	rs80356876	NC_000017.11:43091873:C:A	single nucleotide variant	intron variant|missense variant	Benign	Oct 14, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.3657G>C (p.Glu1219Asp)	BRCA1|LOC126862571	E1219D, E1172D, E1051D, E1091D, E1092D, E1149D, E1171D, E1178D, E1216D, E351D, E1131D, E1177D, E1192D, E1218D, E1107D, E1151D, E1193D, E923D, E1108D, E1130D, E1148D, E1152D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037537	17	41243891	17	43091874	37537	46093	rs80356876	NC_000017.11:43091873:C:G	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3640G>A (p.Glu1214Lys)	BRCA1|LOC126862571	E1214K, E1167K, E1125K, E1126K, E1146K, E1147K, E1173K, E1188K, E1211K, E1172K, E1187K, E918K, E1086K, E1087K, E1102K, E1103K, E1166K, E1213K, E1046K, E1143K, E1144K, E346K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054948	17	41243908	17	43091891	54948	69615	rs80356923	NC_000017.11:43091890:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3608G>A (p.Arg1203Gln)	BRCA1|LOC126862571	R1203Q, R1156Q, R1133Q, R1162Q, R1176Q, R1177Q, R1200Q, R1202Q, R907Q, R1035Q, R1132Q, R1135Q, R1136Q, R1075Q, R1076Q, R1092Q, R1115Q, R1155Q, R1161Q, R335Q, R1091Q, R1114Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054935	17	41243940	17	43091923	54935	69602	rs55930959	NC_000017.11:43091922:C:T	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3601G>A (p.Gly1201Ser)	BRCA1|LOC126862571	G1201S, G1154S, G1089S, G1090S, G1112S, G1131S, G1153S, G1175S, G1200S, G905S, G1073S, G1113S, G1134S, G1174S, G1198S, G1033S, G1074S, G1130S, G1133S, G1159S, G333S, G1160S	not provided|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054932	17	41243947	17	43091930	54932	69599	rs55725337	NC_000017.11:43091929:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3600G>T (p.Gln1200His)	BRCA1|LOC126862571	Q1200H, Q1153H, Q1158H, Q1159H, Q1173H, Q1174H, Q1032H, Q1112H, Q1132H, Q1197H, Q1199H, Q1089H, Q1072H, Q1073H, Q1088H, Q1133H, Q332H, Q904H, Q1111H, Q1129H, Q1130H, Q1152H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054931	17	41243948	17	43091931	54931	69598	rs56214134	NC_000017.11:43091930:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3600G>C (p.Gln1200His)	BRCA1|LOC126862571	Q1200H, Q1153H, Q1072H, Q1112H, Q1129H, Q1130H, Q1133H, Q1174H, Q1199H, Q1073H, Q1088H, Q1152H, Q1158H, Q1159H, Q1173H, Q1197H, Q332H, Q1032H, Q1089H, Q1111H, Q1132H, Q904H	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not provided|BRCA1-related cancer predisposition|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000054930	17	41243948	17	43091931	54930	69597	rs56214134	NC_000017.11:43091930:C:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3548A>G (p.Lys1183Arg)	BRCA1|LOC126862571	K1183R, K1136R, K1056R, K1113R, K1115R, K1182R, K1055R, K1141R, K1015R, K1072R, K1094R, K1095R, K1116R, K1157R, K315R, K887R, K1071R, K1112R, K1135R, K1142R, K1156R, K1180R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041818	17	41244000	17	43091983	41818	50257	rs16942	NC_000017.11:43091982:T:C	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3541G>A (p.Val1181Ile)	BRCA1|LOC126862571	V1181I, V1134I, V1053I, V1093I, V1110I, V1111I, V1133I, V1178I, V1013I, V1069I, V1092I, V1154I, V1054I, V1070I, V1113I, V1139I, V1155I, V1180I, V885I, V313I, V1114I, V1140I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054911	17	41244007	17	43091990	54911	69578	rs56336919	NC_000017.11:43091989:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3463G>C (p.Asp1155His)	BRCA1|LOC126862571	D1155H, D1108H, D1066H, D1128H, D1152H, D987H, D1027H, D1043H, D1085H, D1114H, D1129H, D859H, D1113H, D1028H, D1044H, D1067H, D1084H, D1087H, D1088H, D1107H, D1154H, D287H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054891	17	41244085	17	43092068	54891	69558	rs80357484	NC_000017.11:43092067:C:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3448C>T (p.Pro1150Ser)	BRCA1|LOC126862571	P1150S, P1103S, P1022S, P1039S, P282S, P1023S, P1038S, P1062S, P1082S, P1109S, P1147S, P1061S, P1102S, P1108S, P1124S, P1079S, P1080S, P1083S, P1123S, P1149S, P854S, P982S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054887	17	41244100	17	43092083	54887	69554	rs80357272	NC_000017.11:43092082:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3435T>C (p.Val1145=)	BRCA1|LOC126862571		Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000184013	17	41244113	17	43092096	184013	184966	rs786201222	NC_000017.11:43092095:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.3432G>A (p.Gln1144=)	LOC126862571|BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000187223	17	41244116	17	43092099	187223	184967	rs80356922	NC_000017.11:43092098:C:T	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.3418A>G (p.Ser1140Gly)	BRCA1|LOC126862571	S1140G, S1093G, S1029G, S1051G, S1069G, S1092G, S1114G, S972G, S1013G, S1028G, S1072G, S1099G, S844G, S1012G, S1070G, S1098G, S1113G, S1139G, S272G, S1052G, S1073G, S1137G	BRCA1-related cancer predisposition	VCV000041817	17	41244130	17	43092113	41817	50256	rs2227945	NC_000017.11:43092112:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.3416G>T (p.Ser1139Ile)	BRCA1|LOC126862571	S1139I, S1092I, S1051I, S1072I, S1091I, S1011I, S1012I, S1027I, S1112I, S1136I, S843I, S971I, S1028I, S1050I, S1097I, S1138I, S271I, S1068I, S1069I, S1071I, S1098I, S1113I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054873	17	41244132	17	43092115	54873	69540	rs80357228	NC_000017.11:43092114:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3341AAG[1] (p.Glu1115del)	BRCA1|LOC126862571	E1115del, E1068del, E1004del, E1047del, E819del, E947del, E1026del, E1045del, E1048del, E1074del, E1088del, E1089del, E1114del, E1003del, E1044del, E1067del, E1112del, E1027del, E1073del, E987del, E988del	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054852	17	41244202 - 41244204	17	43092185 - 43092187	54852	69519	rs80358336	NC_000017.11:43092184:CTTCTTC:CTTC	Microsatellite	inframe_indel|inframe_deletion|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3327A>C (p.Lys1109Asn)	BRCA1|LOC126862571	K1109N, K1062N, K1061N, K1067N, K1108N, K1039N, K1042N, K1021N, K1068N, K1083N, K813N, K981N, K1020N, K1038N, K1041N, K1082N, K1106N, K941N, K982N, K997N, K998N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037522	17	41244221	17	43092204	37522	46078	rs41293449	NC_000017.11:43092203:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3302G>A (p.Ser1101Asn)	BRCA1|LOC126862571	S1101N, S1054N, S1013N, S1030N, S1034N, S1060N, S1100N, S973N, S989N, S933N, S1059N, S1074N, S1075N, S1098N, S1012N, S1031N, S1033N, S1053N, S805N, S974N, S990N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054830	17	41244246	17	43092229	54830	69497	rs41293447	NC_000017.11:43092228:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3296C>T (p.Pro1099Leu)	BRCA1|LOC126862571	P1099L, P1052L, P1031L, P1058L, P1098L, P972L, P1010L, P1011L, P1051L, P1057L, P1096L, P971L, P987L, P1028L, P1029L, P1032L, P1072L, P803L, P931L, P1073L, P988L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041816	17	41244252	17	43092235	41816	50255	rs80357201	NC_000017.11:43092234:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3143G>T (p.Gly1048Val)	BRCA1	G1048V, G1001V, G1007V, G1022V, G1045V, G1047V, G960V, G980V, G1000V, G936V, G937V, G978V, G880V, G1006V, G1021V, G752V, G920V, G921V, G959V, G977V, G981V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054777	17	41244405	17	43092388	54777	69444	rs80356899	NC_000017.11:43092387:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.3130A>G (p.Ile1044Val)	BRCA1	I1044V, I997V, I1017V, I1018V, I1041V, I917V, I932V, I973V, I974V, I1002V, I1003V, I955V, I976V, I876V, I916V, I933V, I956V, I1043V, I748V, I977V, I996V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037510	17	41244418	17	43092401	37510	46066	rs80357271	NC_000017.11:43092400:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3119G>A (p.Ser1040Asn)	BRCA1	S1040N, S993N, S1014N, S1039N, S992N, S998N, S872N, S913N, S929N, S969N, S1013N, S928N, S972N, S973N, S1037N, S744N, S912N, S951N, S952N, S970N, S999N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017670	17	41244429	17	43092412	17670	32709	rs4986852	NC_000017.11:43092411:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	E1038G, E991G, E1012G, E742G, E870G, E927G, E971G, E996G, E949G, E911G, E926G, E950G, E967G, E970G, E990G, E1011G, E1035G, E1037G, E910G, E968G, E997G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041815	17	41244435	17	43092418	41815	50254	rs16941	NC_000017.11:43092417:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3083G>A (p.Arg1028His)	BRCA1	R1028H, R981H, R1001H, R916H, R940H, R957H, R980H, R986H, R860H, R901H, R917H, R1027H, R900H, R960H, R961H, R1002H, R1025H, R732H, R939H, R958H, R987H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037507	17	41244465	17	43092448	37507	46063	rs80357459	NC_000017.11:43092447:C:T	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3082C>T (p.Arg1028Cys)	BRCA1	R1028C, R981C, R1002C, R901C, R940C, R957C, R980C, R987C, R1025C, R958C, R732C, R860C, R900C, R916C, R917C, R939C, R961C, R986C, R1001C, R1027C, R960C	BRCA1-related cancer predisposition	VCV000037506	17	41244466	17	43092449	37506	46062	rs80357049	NC_000017.11:43092448:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.3024G>A (p.Met1008Ile)	BRCA1	M1008I, M961I, M881I, M938I, M940I, M960I, M982I, M712I, M840I, M897I, M941I, M981I, M1005I, M880I, M919I, M920I, M937I, M966I, M967I, M1007I, M896I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041814	17	41244524	17	43092507	41814	50253	rs1800704	NC_000017.11:43092506:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.3022A>G (p.Met1008Val)	BRCA1	M1008V, M961V, M897V, M966V, M967V, M1005V, M712V, M937V, M938V, M982V, M840V, M896V, M941V, M981V, M1007V, M880V, M881V, M919V, M920V, M940V, M960V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054755	17	41244526	17	43092509	54755	69422	rs56321129	NC_000017.11:43092508:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2912A>G (p.His971Arg)	BRCA1	H971R, H924R, H803R, H883R, H901R, H903R, H675R, H844R, H882R, H904R, H929R, H970R, H843R, H860R, H923R, H968R, H859R, H900R, H930R, H944R, H945R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000628452	17	41244636	17	43092619	628452	618626	rs1567793641	NC_000017.11:43092618:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2884G>A (p.Glu962Lys)	BRCA1	E962K, E915K, E834K, E835K, E851K, E873K, E794K, E920K, E921K, E935K, E666K, E850K, E891K, E894K, E936K, E874K, E892K, E895K, E914K, E959K, E961K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054709	17	41244664	17	43092647	54709	69376	rs80356955	NC_000017.11:43092646:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2814A>G (p.Pro938=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054688	17	41244734	17	43092717	54688	69355	rs80356851	NC_000017.11:43092716:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2798G>C (p.Gly933Ala)	BRCA1	G933A, G886A, G821A, G885A, G907A, G637A, G805A, G844A, G845A, G865A, G866A, G930A, G765A, G822A, G863A, G891A, G906A, G932A, G806A, G862A, G892A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000233288	17	41244750	17	43092733	233288	236054	rs80356941	NC_000017.11:43092732:C:G	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2773A>C (p.Ile925Leu)	BRCA1	I925L, I878L, I629L, I798L, I837L, I883L, I898L, I922L, I813L, I836L, I854L, I797L, I814L, I857L, I899L, I757L, I855L, I858L, I877L, I884L, I924L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037489	17	41244775	17	43092758	37489	46045	rs4986847	NC_000017.11:43092757:T:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2758G>A (p.Val920Ile)	BRCA1	V920I, V873I, V808I, V852I, V872I, V624I, V793I, V850I, V809I, V831I, V849I, V878I, V917I, V853I, V893I, V894I, V919I, V752I, V792I, V832I, V879I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037488	17	41244790	17	43092773	37488	46044	rs80357361	NC_000017.11:43092772:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2669G>T (p.Gly890Val)	BRCA1	G890V, G843V, G594V, G762V, G820V, G823V, G849V, G887V, G889V, G722V, G779V, G802V, G819V, G822V, G863V, G763V, G778V, G801V, G842V, G848V, G864V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037479	17	41244879	17	43092862	37479	46035	rs80356874	NC_000017.11:43092861:C:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	P871L, P824L, P703L, P743L, P801L, P803L, P845L, P744L, P782L, P783L, P800L, P868L, P804L, P829L, P830L, P844L, P575L, P759L, P760L, P823L, P870L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041812	17	41244936	17	43092919	41812	50251	rs799917	NC_000017.11:43092918:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2597G>A (p.Arg866His)	BRCA1	R866H, R819H, R738H, R755H, R795H, R824H, R839H, R863H, R799H, R570H, R739H, R754H, R777H, R818H, R825H, R840H, R865H, R698H, R778H, R796H, R798H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054613	17	41244951	17	43092934	54613	69280	rs80356911	NC_000017.11:43092933:C:T	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2596C>T (p.Arg866Cys)	BRCA1	R866C, R819C, R738C, R754C, R755C, R778C, R798C, R799C, R865C, R570C, R777C, R796C, R825C, R698C, R795C, R824C, R839C, R739C, R818C, R840C, R863C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041811	17	41244952	17	43092935	41811	50250	rs41286300	NC_000017.11:43092934:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2584A>G (p.Lys862Glu)	BRCA1	K862E, K815E, K773E, K792E, K794E, K566E, K735E, K795E, K820E, K861E, K694E, K734E, K750E, K751E, K774E, K791E, K836E, K859E, K814E, K821E, K835E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037476	17	41244964	17	43092947	37476	46032	rs80356927	NC_000017.11:43092946:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Y856H, Y809H, Y786H, Y808H, Y728H, Y768H, Y814H, Y815H, Y829H, Y767H, Y830H, Y853H, Y560H, Y688H, Y729H, Y744H, Y745H, Y785H, Y788H, Y789H, Y855H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054604	17	41244982	17	43092965	54604	69271	rs80356892	NC_000017.11:43092964:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2525A>G (p.Glu842Gly)	BRCA1	E842G, E795G, E731G, E753G, E841G, E771G, E774G, E775G, E801G, E839G, E546G, E674G, E754G, E794G, E800G, E815G, E714G, E715G, E730G, E772G, E816G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000091592	17	41245023	17	43093006	91592	97069	rs28897684	NC_000017.11:43093005:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2522G>A (p.Arg841Gln)	BRCA1	R841Q, R794Q, R714Q, R729Q, R773Q, R799Q, R800Q, R673Q, R753Q, R793Q, R815Q, R545Q, R713Q, R730Q, R770Q, R771Q, R752Q, R774Q, R814Q, R838Q, R840Q	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054591	17	41245026	17	43093009	54591	69258	rs80357337	NC_000017.11:43093008:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2521C>T (p.Arg841Trp)	BRCA1	R841W, R794W, R840W, R673W, R730W, R752W, R799W, R838W, R545W, R713W, R770W, R773W, R814W, R815W, R729W, R753W, R771W, R800W, R714W, R774W, R793W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000017681	17	41245027	17	43093010	17681	32720	rs1800709	NC_000017.11:43093009:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2515C>T (p.His839Tyr)	BRCA1	H543Y, H671Y, H711Y, H712Y, H727Y, H728Y, H750Y, H751Y, H768Y, H769Y, H771Y, H772Y, H791Y, H792Y, H797Y, H798Y, H812Y, H813Y, H836Y, H838Y, H839Y	Ovarian cancer	VCV002445306	17	41245033	17	43093016	2445306	2419032	rs2154373229	NC_000017.11:43093015:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jan 1, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2477C>A (p.Thr826Lys)	BRCA1	T826K, T779K, T738K, T755K, T784K, T800K, T530K, T715K, T737K, T759K, T658K, T698K, T758K, T778K, T799K, T825K, T699K, T714K, T756K, T785K, T823K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037473	17	41245071	17	43093054	37473	46029	rs28897683	NC_000017.11:43093053:G:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2458A>G (p.Lys820Glu)	BRCA1	K820E, K773E, K524E, K753E, K779E, K817E, K693E, K708E, K732E, K750E, K794E, K652E, K709E, K731E, K749E, K772E, K778E, K793E, K692E, K752E, K819E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041810	17	41245090	17	43093073	41810	50249	rs56082113	NC_000017.11:43093072:T:C	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	N810Y, N763Y, N642Y, N721Y, N722Y, N768Y, N769Y, N809Y, N699Y, N742Y, N762Y, N783Y, N784Y, N698Y, N514Y, N682Y, N683Y, N739Y, N740Y, N743Y, N807Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054567	17	41245120	17	43093103	54567	69234	rs28897682	NC_000017.11:43093102:T:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2412G>C (p.Gln804His)	BRCA1	Q804H, Q757H, Q676H, Q693H, Q734H, Q778H, Q777H, Q803H, Q508H, Q636H, Q715H, Q756H, Q801H, Q677H, Q692H, Q716H, Q733H, Q736H, Q737H, Q762H, Q763H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054561	17	41245136	17	43093119	54561	69228	rs55746541	NC_000017.11:43093118:C:G	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2351C>T (p.Ser784Leu)	BRCA1	S784L, S737L, S656L, S673L, S695L, S713L, S714L, S736L, S742L, S757L, S758L, S616L, S657L, S743L, S783L, S488L, S696L, S716L, S717L, S672L, S781L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037464	17	41245197	17	43093180	37464	46020	rs55914168	NC_000017.11:43093179:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2347A>G (p.Ile783Val)	BRCA1	I783V, I736V, I695V, I712V, I715V, I780V, I656V, I671V, I735V, I742V, I757V, I487V, I655V, I694V, I716V, I782V, I615V, I672V, I713V, I741V, I756V	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054541	17	41245201	17	43093184	54541	69208	rs80356948	NC_000017.11:43093183:T:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2335A>T (p.Thr779Ser)	BRCA1	T732S, T779S, T776S, T483S, T652S, T667S, T691S, T731S, T738S, T778S, T711S, T752S, T611S, T651S, T668S, T690S, T708S, T709S, T712S, T737S, T753S	Hereditary breast ovarian cancer syndrome	VCV001325663	17	41245213	17	43093196	1325663	1315928	rs1348270931	NC_000017.11:43093195:T:A	single nucleotide variant	missense variant|intron variant	Benign	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.2315T>C (p.Val772Ala)	BRCA1	V772A, V725A, V476A, V684A, V702A, V724A, V731A, V771A, V604A, V644A, V660A, V661A, V730A, V746A, V745A, V769A, V645A, V683A, V701A, V704A, V705A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041809	17	41245233	17	43093216	41809	50248	rs80357467	NC_000017.11:43093215:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2311T>C (p.Leu771=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125554	17	41245237	17	43093220	125554	131092	rs16940	NC_000017.11:43093219:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2286A>T (p.Arg762Ser)	BRCA1	R762S, R715S, R635S, R651S, R714S, R736S, R634S, R650S, R674S, R694S, R720S, R692S, R695S, R721S, R735S, R761S, R466S, R594S, R673S, R691S, R759S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054522	17	41245262	17	43093245	54522	69189	rs273898682	NC_000017.11:43093244:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2232T>C (p.Ala744=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054508	17	41245316	17	43093299	54508	69175	rs4986846	NC_000017.11:43093298:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2207A>C (p.Glu736Ala)	BRCA1	E736A, E689A, E440A, E609A, E668A, E694A, E733A, E735A, E624A, E625A, E647A, E648A, E695A, E710A, E568A, E665A, E688A, E608A, E666A, E669A, E709A	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000037455	17	41245341	17	43093324	37455	46011	rs397507196	NC_000017.11:43093323:T:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.2180C>T (p.Pro727Leu)	BRCA1	P727L, P680L, P599L, P639L, P659L, P660L, P615L, P657L, P686L, P724L, P726L, P431L, P559L, P600L, P700L, P701L, P616L, P638L, P656L, P679L, P685L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054486	17	41245368	17	43093351	54486	69153	rs80356912	NC_000017.11:43093350:G:A	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2167A>G (p.Asn723Asp)	BRCA1	N723D, N676D, N596D, N611D, N696D, N722D, N612D, N656D, N427D, N595D, N635D, N652D, N655D, N682D, N697D, N555D, N634D, N653D, N675D, N681D, N720D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037454	17	41245381	17	43093364	37454	46010	rs4986845	NC_000017.11:43093363:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2155A>G (p.Lys719Glu)	BRCA1	K672E, K551E, K630E, K649E, K671E, K677E, K678E, K692E, K423E, K652E, K591E, K648E, K693E, K718E, K592E, K607E, K608E, K631E, K651E, K716E	BRCA1-related cancer predisposition	VCV000037452	17	41245393	17	43093376	37452	46008	rs80357147	NC_000017.11:43093375:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.2109A>G (p.Thr703=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054461	17	41245439	17	43093422	54461	69128	rs4986844	NC_000017.11:43093421:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.2083G>T (p.Asp695Tyr)	BRCA1	D695Y, D648Y, D527Y, D567Y, D583Y, D584Y, D628Y, D668Y, D653Y, D654Y, D399Y, D607Y, D627Y, D669Y, D568Y, D606Y, D624Y, D625Y, D647Y, D692Y, D694Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054456	17	41245465	17	43093448	54456	69123	rs28897681	NC_000017.11:43093447:C:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.2082C>T (p.Ser694=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125536	17	41245466	17	43093449	125536	131074	rs1799949	NC_000017.11:43093448:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	D693N, D646N, D582N, D605N, D622N, D652N, D690N, D397N, D565N, D581N, D626N, D651N, D692N, D525N, D566N, D645N, D666N, D604N, D623N, D625N, D667N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041808	17	41245471	17	43093454	41808	50247	rs4986850	NC_000017.11:43093453:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.2002C>T (p.Leu668Phe)	BRCA1	L668F, L621F, L541F, L665F, L500F, L556F, L579F, L580F, L600F, L627F, L641F, L540F, L598F, L601F, L620F, L667F, L372F, L557F, L597F, L626F, L642F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037441	17	41245546	17	43093529	37441	45997	rs80357250	NC_000017.11:43093528:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1974G>A (p.Met658Ile)	BRCA1	M611I, M658I, M546I, M547I, M655I, M362I, M531I, M591I, M490I, M569I, M570I, M587I, M588I, M617I, M632I, M530I, M590I, M610I, M616I, M631I, M657I	Hereditary breast ovarian cancer syndrome	VCV001168433	17	41245574	17	43093557	1168433	1157986	rs55678461	NC_000017.11:43093556:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 14, 2020	criteria provided, single submitter							
NM_007294.4(BRCA1):c.1971A>G (p.Gln657=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054424	17	41245577	17	43093560	54424	69091	rs28897679	NC_000017.11:43093559:T:C	single nucleotide variant	synonymous variant|intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1927A>G (p.Ser643Gly)	BRCA1	S643G, S596G, S347G, S516G, S572G, S595G, S617G, S554G, S576G, S602G, S531G, S616G, S642G, S475G, S515G, S532G, S555G, S573G, S575G, S601G, S640G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054402	17	41245621	17	43093604	54402	69069	rs80357105	NC_000017.11:43093603:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1924G>C (p.Asp642His)	BRCA1	D642H, D595H, D572H, D639H, D641H, D514H, D531H, D594H, D616H, D346H, D515H, D553H, D571H, D574H, D575H, D600H, D474H, D530H, D554H, D601H, D615H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054401	17	41245624	17	43093607	54401	69068	rs80357344	NC_000017.11:43093606:C:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1865C>T (p.Ala622Val)	BRCA1	A622V, A575V, A326V, A454V, A495V, A555V, A580V, A581V, A595V, A596V, A511V, A533V, A551V, A552V, A621V, A510V, A554V, A619V, A494V, A534V, A574V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054371	17	41245683	17	43093666	54371	69038	rs56039126	NC_000017.11:43093665:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1843TCT[1] (p.Ser616del)	BRCA1	S616del, S569del, S320del, S489del, S505del, S568del, S574del, S575del, S589del, S488del, S504del, S528del, S549del, S613del, S527del, S590del, S615del, S448del, S545del, S546del, S548del	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037430	17	41245700 - 41245702	17	43093683 - 43093685	37430	45986	rs80358329	NC_000017.11:43093682:AGAAGA:AGA	Microsatellite	inframe_indel|inframe_deletion|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1834A>G (p.Arg612Gly)	BRCA1	R612G, R565G, R500G, R571G, R611G, R524G, R545G, R564G, R570G, R586G, R316G, R484G, R542G, R585G, R444G, R485G, R501G, R523G, R541G, R544G, R609G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054367	17	41245714	17	43093697	54367	69034	rs80357245	NC_000017.11:43093696:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1789G>A (p.Glu597Lys)	BRCA1	E597K, E550K, E301K, E527K, E469K, E470K, E508K, E530K, E596K, E429K, E486K, E555K, E570K, E571K, E594K, E485K, E509K, E526K, E529K, E549K, E556K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041806	17	41245759	17	43093742	41806	50245	rs55650082	NC_000017.11:43093741:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1703C>T (p.Pro568Leu)	BRCA1	P568L, P521L, P441L, P541L, P456L, P479L, P497L, P520L, P527L, P542L, P565L, P480L, P498L, P500L, P567L, P272L, P400L, P440L, P457L, P501L, P526L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054329	17	41245845	17	43093828	54329	68996	rs80356910	NC_000017.11:43093827:G:A	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1648A>C (p.Asn550His)	BRCA1	N550H, N503H, N461H, N482H, N254H, N382H, N479H, N483H, N508H, N523H, N439H, N480H, N502H, N524H, N422H, N423H, N438H, N462H, N509H, N547H, N549H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037423	17	41245900	17	43093883	37423	45979	rs56012641	NC_000017.11:43093882:T:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1616C>T (p.Thr539Met)	BRCA1	T539M, T492M, T371M, T412M, T469M, T512M, T513M, T538M, T411M, T471M, T472M, T498M, T427M, T450M, T468M, T497M, T243M, T428M, T451M, T491M, T536M	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054310	17	41245932	17	43093915	54310	68977	rs80357374	NC_000017.11:43093914:G:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1534C>T (p.Leu512Phe)	BRCA1	L512F, L465F, L216F, L400F, L441F, L442F, L471F, L509F, L384F, L424F, L445F, L486F, L344F, L401F, L444F, L470F, L385F, L423F, L464F, L485F, L511F	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037420	17	41246014	17	43093997	37420	45976	rs41286294	NC_000017.11:43093996:G:A	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1511G>A (p.Arg504His)	BRCA1	R504H, R457H, R415H, R433H, R434H, R456H, R463H, R208H, R336H, R377H, R392H, R462H, R376H, R436H, R477H, R501H, R393H, R416H, R437H, R478H, R503H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054278	17	41246037	17	43094020	54278	68945	rs56272539	NC_000017.11:43094019:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1487G>A (p.Arg496His)	BRCA1	R496H, R449H, R385H, R408H, R425H, R428H, R495H, R328H, R368H, R426H, R448H, R469H, R200H, R369H, R455H, R470H, R384H, R407H, R429H, R454H, R493H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041805	17	41246061	17	43094044	41805	50244	rs28897677	NC_000017.11:43094043:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1486C>T (p.Arg496Cys)	BRCA1	R496C, R449C, R200C, R454C, R384C, R407C, R455C, R493C, R495C, R328C, R408C, R426C, R428C, R448C, R469C, R368C, R369C, R385C, R425C, R429C, R470C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037416	17	41246062	17	43094045	37416	45972	rs28897676	NC_000017.11:43094044:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1474A>G (p.Ile492Val)	BRCA1	I445V, I492V, I364V, I365V, I381V, I403V, I444V, I489V, I196V, I422V, I425V, I451V, I404V, I421V, I491V, I324V, I380V, I424V, I450V, I465V, I466V	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000660456	17	41246074	17	43094057	660456	646028	rs1597875858	NC_000017.11:43094056:T:C	single nucleotide variant	intron variant|missense variant	Benign/Likely benign	Jul 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1458T>A (p.Phe486Leu)	BRCA1	F486L, F439L, F416L, F419L, F460L, F318L, F359L, F398L, F418L, F459L, F485L, F358L, F374L, F397L, F483L, F190L, F375L, F415L, F438L, F444L, F445L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000054259	17	41246090	17	43094073	54259	68926	rs80357400	NC_000017.11:43094072:A:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Sep 9, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1456T>C (p.Phe486Leu)	BRCA1	F486L, F439L, F374L, F375L, F416L, F419L, F444L, F358L, F398L, F438L, F483L, F318L, F397L, F415L, F485L, F190L, F359L, F418L, F445L, F459L, F460L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054258	17	41246092	17	43094075	54258	68925	rs55906931	NC_000017.11:43094074:A:G	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1427A>G (p.His476Arg)	BRCA1	H476R, H429R, H364R, H434R, H449R, H180R, H308R, H365R, H388R, H405R, H406R, H428R, H450R, H475R, H349R, H409R, H473R, H348R, H387R, H408R, H435R	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054251	17	41246121	17	43094104	54251	68918	rs55720177	NC_000017.11:43094103:T:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1418A>T (p.Asn473Ile)	BRCA1	N473I, N426I, N345I, N346I, N361I, N385I, N432I, N470I, N177I, N384I, N402I, N405I, N447I, N472I, N362I, N406I, N431I, N305I, N403I, N425I, N446I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054249	17	41246130	17	43094113	54249	68916	rs80357057	NC_000017.11:43094112:T:A	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1418A>G (p.Asn473Ser)	BRCA1	N473S, N426S, N177S, N384S, N405S, N406S, N345S, N361S, N402S, N431S, N432S, N446S, N472S, N362S, N403S, N425S, N305S, N346S, N385S, N447S, N470S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054248	17	41246130	17	43094113	54248	68915	rs80357057	NC_000017.11:43094112:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1392C>T (p.Thr464=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136541	17	41246156	17	43094139	136541	140244	rs533802049	NC_000017.11:43094138:G:A	single nucleotide variant	intron variant|synonymous variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.1383T>A (p.Phe461Leu)	BRCA1	F461L, F414L, F419L, F458L, F460L, F334L, F372L, F373L, F394L, F413L, F435L, F293L, F333L, F349L, F390L, F391L, F393L, F434L, F165L, F350L, F420L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054228	17	41246165	17	43094148	54228	68895	rs56046357	NC_000017.11:43094147:A:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1233T>G (p.Asp411Glu)	BRCA1	D411E, D364E, D300E, D323E, D344E, D410E, D283E, D322E, D340E, D384E, D385E, D408E, D115E, D243E, D284E, D299E, D370E, D341E, D343E, D363E, D369E	BRCA1-related cancer predisposition	VCV000041804	17	41246315	17	43094298	41804	50243	rs80357024	NC_000017.11:43094297:A:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.1159T>A (p.Ser387Thr)	BRCA1	S387T, S340T, S219T, S276T, S298T, S345T, S91T, S260T, S320T, S384T, S386T, S259T, S275T, S299T, S316T, S317T, S319T, S361T, S339T, S346T, S360T	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000231852	17	41246389	17	43094372	231852	236139	rs876659403	NC_000017.11:43094371:A:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1137T>G (p.Ile379Met)	BRCA1	I379M, I332M, I291M, I309M, I337M, I352M, I353M, I267M, I268M, I290M, I338M, I378M, I83M, I211M, I251M, I252M, I308M, I311M, I312M, I331M, I376M	Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Pancreatic cancer, susceptibility to, 4|Familial cancer of breast|BRCA1-related cancer predisposition|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000054143	17	41246411	17	43094394	54143	68810	rs56128296	NC_000017.11:43094393:A:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1106_1108del (p.Asp369del)	BRCA1	D369del, D322del, D258del, D281del, D328del, D241del, D280del, D302del, D327del, D343del, D242del, D257del, D298del, D301del, D321del, D342del, D73del, D201del, D299del, D366del, D368del	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054130	17	41246440 - 41246442	17	43094423 - 43094425	54130	68797	rs80358325	NC_000017.11:43094422:CATC:C	Deletion	inframe_indel|inframe_deletion|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1105G>A (p.Asp369Asn)	BRCA1	D369N, D322N, D257N, D73N, D201N, D281N, D302N, D321N, D327N, D328N, D241N, D258N, D280N, D299N, D301N, D342N, D343N, D366N, D368N, D242N, D298N	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037390	17	41246443	17	43094426	37390	45946	rs56056711	NC_000017.11:43094425:C:T	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1067A>G (p.Gln356Arg)	BRCA1	Q356R, Q309R, Q314R, Q315R, Q353R, Q244R, Q268R, Q288R, Q329R, Q355R, Q60R, Q228R, Q245R, Q267R, Q289R, Q188R, Q229R, Q285R, Q286R, Q308R, Q330R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041803	17	41246481	17	43094464	41803	50242	rs1799950	NC_000017.11:43094463:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.1036C>T (p.Pro346Ser)	BRCA1	P346S, P299S, P275S, P298S, P304S, P320S, P345S, P178S, P218S, P234S, P50S, P235S, P257S, P276S, P279S, P305S, P319S, P343S, P219S, P258S, P278S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037389	17	41246512	17	43094495	37389	45945	rs80357015	NC_000017.11:43094494:G:A	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.1026G>A (p.Leu342=)	BRCA1		Hereditary cancer-predisposing syndrome|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome	VCV000481481	17	41246522	17	43094505	481481	479459	rs1171571879	NC_000017.11:43094504:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.1001C>T (p.Pro334Leu)	BRCA1	P334L, P287L, P286L, P292L, P333L, P166L, P206L, P223L, P245L, P246L, P263L, P307L, P308L, P207L, P266L, P267L, P331L, P222L, P264L, P293L, P38L	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054099	17	41246547	17	43094530	54099	68766	rs41286290	NC_000017.11:43094529:G:A	single nucleotide variant	intron variant|missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.997A>G (p.Thr333Ala)	BRCA1	T333A, T286A, T206A, T222A, T244A, T245A, T266A, T292A, T221A, T262A, T263A, T306A, T330A, T332A, T37A, T165A, T265A, T291A, T205A, T285A, T307A	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000184709	17	41246551	17	43094534	184709	185085	rs786201634	NC_000017.11:43094533:T:C	single nucleotide variant	missense variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.981A>G (p.Thr327=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055771	17	41246567	17	43094550	55771	70438	rs1800063	NC_000017.11:43094549:T:C	single nucleotide variant	intron variant|synonymous variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.958A>C (p.Arg320=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000427247	17	41246590	17	43094573	427247	416513	rs1131692065	NC_000017.11:43094572:T:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.946A>G (p.Ser316Gly)	BRCA1	S316G, S269G, S148G, S20G, S245G, S289G, S227G, S274G, S315G, S204G, S268G, S275G, S290G, S313G, S188G, S189G, S205G, S228G, S246G, S248G, S249G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037709	17	41246602	17	43094585	37709	46265	rs55874646	NC_000017.11:43094584:T:C	single nucleotide variant	intron variant|missense variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.891G>T (p.Met297Ile)	BRCA1	M297I, M250I, M169I, M208I, M227I, M230I, M249I, M186I, M1I, M209I, M226I, M256I, M270I, M294I, M129I, M255I, M271I, M170I, M185I, M229I, M296I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000812549	17	41246657	17	43094640	812549	800792	rs80357103	NC_000017.11:43094639:C:A	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.891G>A (p.Met297Ile)	BRCA1	M297I, M250I, M129I, M208I, M227I, M229I, M230I, M271I, M1I, M255I, M270I, M169I, M294I, M296I, M170I, M185I, M186I, M209I, M226I, M249I, M256I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055743	17	41246657	17	43094640	55743	70410	rs80357103	NC_000017.11:43094639:C:T	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.839C>G (p.Ala280Gly)	BRCA1	A280G, A233G, A152G, A153G, A212G, A253G, A168G, A192G, A209G, A213G, A112G, A232G, A279G, A169G, A191G, A210G, A238G, A239G, A254G, A277G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055731	17	41246709	17	43094692	55731	70398	rs80357199	NC_000017.11:43094691:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.827C>G (p.Thr276Arg)	BRCA1	T276R, T229R, T149R, T209R, T250R, T164R, T205R, T208R, T234R, T148R, T165R, T188R, T235R, T275R, T108R, T187R, T206R, T228R, T249R, T273R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037706	17	41246721	17	43094704	37706	46262	rs80357436	NC_000017.11:43094703:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.824G>A (p.Gly275Asp)	BRCA1	G275D, G228D, G248D, G274D, G164D, G227D, G272D, G147D, G187D, G204D, G207D, G234D, G249D, G107D, G148D, G163D, G208D, G233D, G186D, G205D	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055726	17	41246724	17	43094707	55726	70393	rs397509327	NC_000017.11:43094706:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.823G>A (p.Gly275Ser)	BRCA1	G275S, G228S, G205S, G272S, G107S, G148S, G164S, G186S, G207S, G208S, G234S, G249S, G187S, G204S, G233S, G274S, G147S, G163S, G227S, G248S	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055725	17	41246725	17	43094708	55725	70392	rs8176153	NC_000017.11:43094707:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.811G>A (p.Val271Met)	BRCA1	V271M, V224M, V103M, V159M, V183M, V200M, V201M, V230M, V270M, V143M, V160M, V182M, V203M, V244M, V144M, V204M, V223M, V229M, V245M, V268M	BRCA1-related cancer predisposition	VCV000055720	17	41246737	17	43094720	55720	70387	rs80357244	NC_000017.11:43094719:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	May 23, 2025	reviewed by expert panel							
NM_007294.4(BRCA1):c.807G>A (p.Leu269=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136540	17	41246741	17	43094724	136540	140243	rs149867679	NC_000017.11:43094723:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.804C>T (p.Asn268=)	BRCA1		Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000415558	17	41246744	17	43094727	415558	402074	rs771076131	NC_000017.11:43094726:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.795T>C (p.Ser265=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055708	17	41246753	17	43094736	55708	70375	rs201441987	NC_000017.11:43094735:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.765G>A (p.Glu255=)	BRCA1		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast	VCV000136091	17	41246783	17	43094766	136091	139803	rs62625299	NC_000017.11:43094765:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.736T>G (p.Leu246Val)	BRCA1	L246V, L199V, L118V, L119V, L134V, L219V, L243V, L176V, L179V, L201V, L204V, L245V, L158V, L175V, L198V, L220V, L135V, L157V, L178V, L205V, L78V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041835	17	41246812	17	43094795	41835	50274	rs28897675	NC_000017.11:43094794:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	BRCA1	H239R, H192R, H128R, H150R, H194R, H213R, H112R, H191R, H238R, H71R, H168R, H169R, H171R, H172R, H197R, H111R, H127R, H151R, H198R, H212R, H236R	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055677	17	41246832	17	43094815	55677	70344	rs80357396	NC_000017.11:43094814:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.671-13dup	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001166737	17	41246889 - 41246890	17	43094872 - 43094873	1166737	1157987	rs8176152	NC_000017.11:43094872:AAAAA:AAAAAA	Duplication	intron variant	Benign	Oct 21, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.671-12del	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000096955	17	41246889	17	43094872	96955	102858	rs273902781	NC_000017.11:43094871:C:	Deletion	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.671-178G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209444	17	41247055	17	43095038	209444	206403	rs8176151	NC_000017.11:43095037:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.671-244_671-243insGTA	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209445	17	41247120 - 41247121	17	43095103 - 43095104	209445	206404	rs200368134	NC_000017.11:43095103::TAC	Insertion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.671-248_671-246dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000127125	17	41247122 - 41247123	17	43095105 - 43095106	127125	132628	rs5820483	NC_000017.11:43095105:CCT:CCTCCT	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.670+259T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209447	17	41247604	17	43095587	209447	206406	rs7503154	NC_000017.11:43095586:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.670+256T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209448	17	41247607	17	43095590	209448	206407	rs182524124	NC_000017.11:43095589:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.670+16G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000142297	17	41247847	17	43095830	142297	152011	rs199916228	NC_000017.11:43095829:C:T	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.663A>G (p.Ala221=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV001325668	17	41247870	17	43095853	1325668	1315933	rs375952040	NC_000017.11:43095852:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.652T>G (p.Leu218Val)	BRCA1	L171V, L218V, L147V, L191V, L91V, L148V, L170V, L173V, L192V, L90V, L215V, L217V	not specified	VCV001684697	17	41247881	17	43095864	1684697	1676725	rs765950064	NC_000017.11:43095863:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	May 4, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.641A>G (p.Asp214Gly)	BRCA1	D214G, D167G, D143G, D166G, D87G, D144G, D211G, D187G, D169G, D188G, D213G, D86G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037689	17	41247892	17	43095875	37689	46245	rs55680408	NC_000017.11:43095874:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.3(BRCA1):c.[594-2A>C;641A>G]	BRCA1	D214G, D167G, D143G, D166G, D87G, D144G, D211G, D187G, D169G, D188G, D213G, D86G	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000236265	17|17	41247941	17|17	43095924	236265	46242|46245	rs80358033|rs55680408	NC_000017.11:43095923:T:G|NC_000017.11:43095874:T:C	Haplotype	splice acceptor variant|intron variant|missense variant|non-coding transcript variant	Benign	Apr 15, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-2A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037686	17	41247941	17	43095924	37686	46242	rs80358033	NC_000017.11:43095923:T:G	single nucleotide variant	splice acceptor variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-34T>C	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225726	17	41247973	17	43095956	225726	227568	rs147314539	NC_000017.11:43095955:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.594-225G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209449	17	41248164	17	43096147	209449	206408	rs8176147	NC_000017.11:43096146:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-465_594-455dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264829	17	41248393 - 41248394	17	43096376 - 43096377	264829	259579	rs71160005	NC_000017.11:43096376:AAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-458T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264836	17	41248397	17	43096380	264836	259580	rs537806106	NC_000017.11:43096379:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-545C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209450	17	41248484	17	43096467	209450	206409	rs66499067	NC_000017.11:43096466:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-622G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264812	17	41248561	17	43096544	264812	259581	rs189108346	NC_000017.11:43096543:C:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.594-650del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264852	17	41248589	17	43096572	264852	259582	rs34226398	NC_000017.11:43096571:AAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAA	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.593+357C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264787	17	41248904	17	43096887	264787	259583	rs8176146	NC_000017.11:43096886:G:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.593+167T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209451	17	41249094	17	43097077	209451	206410	rs8176145	NC_000017.11:43097076:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.593+3G>A	BRCA1		not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified	VCV000091657	17	41249258	17	43097241	91657	97134	rs80358013	NC_000017.11:43097240:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.591C>T (p.Cys197=)	BRCA1		BRCA1-related cancer predisposition	VCV000055642	17	41249263	17	43097246	55642	70309	rs1799965	NC_000017.11:43097245:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.571G>A (p.Val191Ile)	BRCA1	V191I, V144I, V120I, V121I, V146I, V64I, V164I, V165I, V188I, V190I, V143I, V63I	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037684	17	41249283	17	43097266	37684	46240	rs80357090	NC_000017.11:43097265:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	BRCA1	S186Y, S139Y, S183Y, S115Y, S185Y, S59Y, S116Y, S160Y, S138Y, S141Y, S159Y, S58Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055635	17	41249297	17	43097280	55635	70302	rs55688530	NC_000017.11:43097279:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-3del	BRCA1		Hereditary breast ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000125887	17	41249309	17	43097292	125887	131425	rs398122353	NC_000017.11:43097291:AAAAAA:AAAAA	Deletion	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.548-12del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV001648680	17	41249318	17	43097301	1648680	1600833	rs1567804289	NC_000017.11:43097300:CCCCCC:CCCCC	Deletion	intron variant	Benign	Apr 6, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.548-17G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037675	17	41249323	17	43097306	37675	46231	rs80358014	NC_000017.11:43097305:C:A	single nucleotide variant	intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-18del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000091655	17	41249324	17	43097307	91655	97132	rs398122701	NC_000017.11:43097306:AAAAAA:AAAAA	Deletion	intron variant	Benign	Dec 4, 2024	criteria provided, single submitter							
NM_007294.4(BRCA1):c.548-58del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125889	17	41249364	17	43097347	125889	131427	rs8176144	NC_000017.11:43097346:AAAAAAA:AAAAAA	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-80T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209452	17	41249386	17	43097369	209452	206411	rs8176143	NC_000017.11:43097368:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-293G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209453	17	41249599	17	43097582	209453	206412	rs117281398	NC_000017.11:43097581:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-721C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209454	17	41250027	17	43098010	209454	206413	rs799918	NC_000017.11:43098009:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-916del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209455	17	41250222	17	43098205	209455	206414	rs200081820	NC_000017.11:43098204:TTTTTTT:TTTTTT	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.548-1135A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209456	17	41250441	17	43098424	209456	206415	rs145668291	NC_000017.11:43098423:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+1209G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209457	17	41250583	17	43098566	209457	206416	rs181936042	NC_000017.11:43098565:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+1113_547+1114insA	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209458	17	41250678 - 41250679	17	43098661 - 43098662	209458	206417	rs35693790	NC_000017.11:43098661::T	Insertion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+898C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209459	17	41250894	17	43098877	209459	206418	rs143460481	NC_000017.11:43098876:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+869A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209460	17	41250923	17	43098906	209460	206419	rs799919	NC_000017.11:43098905:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+791del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264822	17	41251001	17	43098984	264822	259584	rs577010874	NC_000017.11:43098983:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTT	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+364_547+365del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209461	17	41251427 - 41251428	17	43099410 - 43099411	209461	206420	rs201060127	NC_000017.11:43099409:ACA:A	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+322A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209462	17	41251470	17	43099453	209462	206421	rs142085161	NC_000017.11:43099452:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+297G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209463	17	41251495	17	43099478	209463	206422	rs8176141	NC_000017.11:43099477:C:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+284C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209464	17	41251508	17	43099491	209464	206423	rs7219966	NC_000017.11:43099490:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+146A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125879	17	41251646	17	43099629	125879	131417	rs8176140	NC_000017.11:43099628:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.547+20del	BRCA1		Hereditary breast ovarian cancer syndrome	VCV002033448	17	41251772	17	43099755	2033448	2100380	rs1223085865	NC_000017.11:43099754:AAAAAA:AAAAA	Deletion	intron variant	Benign	Sep 30, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.547+8T>G	BRCA1		not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000438941	17	41251784	17	43099767	438941	432923	rs762224894	NC_000017.11:43099766:A:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.536A>G (p.Tyr179Cys)	BRCA1	Y179C, Y132C, Y109C, Y178C, Y51C, Y134C, Y176C, Y131C, Y152C, Y153C, Y52C, Y108C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037661	17	41251803	17	43099786	37661	46217	rs56187033	NC_000017.11:43099785:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.508C>T (p.Arg170Trp)	BRCA1	R170W, R123W, R144W, R99W, R100W, R122W, R167W, R169W, R43W, R125W, R143W, R42W	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055393	17	41251831	17	43099814	55393	70060	rs80357325	NC_000017.11:43099813:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.463C>G (p.Gln155Glu)	BRCA1	Q155E, Q108E, Q107E, Q128E, Q27E, Q84E, Q85E, Q110E, Q129E, Q152E, Q154E, Q28E	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055247	17	41251876	17	43099859	55247	69914	rs80357180	NC_000017.11:43099858:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-34C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125864	17	41251931	17	43099914	125864	131402	rs799923	NC_000017.11:43099913:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-678C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209466	17	41252575	17	43100558	209466	206424	rs10445316	NC_000017.11:43100557:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-692TA[6]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209465	17	41252576 - 41252577	17	43100559 - 43100560	209465	206425	rs530582154	NC_000017.11:43100558:TATATATATATATA:TATATATATATA	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-680T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209467	17	41252577	17	43100560	209467	206426	rs799924	NC_000017.11:43100559:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-702AT[5]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264796	17	41252591 - 41252592	17	43100574 - 43100575	264796	259585	rs200639029	NC_000017.11:43100574:ATATATATA:ATATATATATA	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-715AT[4]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209469	17	41252603 - 41252604	17	43100586 - 43100587	209469	206428	rs201678971	NC_000017.11:43100585:ATATATATAT:ATATATAT	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-714T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209470	17	41252611	17	43100594	209470	206429	rs799925	NC_000017.11:43100593:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-715A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209471	17	41252612	17	43100595	209471	206430	rs10445317	NC_000017.11:43100594:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-716A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209472	17	41252613	17	43100596	209472	206431	rs10445318	NC_000017.11:43100595:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-737AT[5]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209473	17	41252626 - 41252627	17	43100609 - 43100610	209473	206432	rs200083681	NC_000017.11:43100609:ATATATATA:ATATATATATA	Microsatellite	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-740_442-738del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264783	17	41252635 - 41252637	17	43100618 - 43100620	264783	259586	rs538378944	NC_000017.11:43100617:AACA:A	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-810_442-809insAAC	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264776	17	41252706 - 41252707	17	43100689 - 43100690	264776	259587	rs574913562	NC_000017.11:43100689:T:TGTT	Insertion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-983G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209474	17	41252880	17	43100863	209474	206433	rs148500539	NC_000017.11:43100862:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-1431G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209475	17	41253328	17	43101311	209475	206434	rs111387199	NC_000017.11:43101310:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.442-1770C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209476	17	41253667	17	43101650	209476	206435	rs142854457	NC_000017.11:43101649:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+2009G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264779	17	41254130	17	43102113	264779	259588	rs545752115	NC_000017.11:43102112:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1990C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209477	17	41254149	17	43102132	209477	206436	rs183687593	NC_000017.11:43102131:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1965T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209478	17	41254174	17	43102157	209478	206437	rs10445320	NC_000017.11:43102156:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1734G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264778	17	41254405	17	43102388	264778	259589	rs10445303	NC_000017.11:43102387:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1653A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209479	17	41254486	17	43102469	209479	206438	rs10445321	NC_000017.11:43102468:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1416C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209480	17	41254723	17	43102706	209480	206439	rs34765977	NC_000017.11:43102705:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1383T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264805	17	41254756	17	43102739	264805	259590	rs537597375	NC_000017.11:43102738:A:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1382A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264786	17	41254757	17	43102740	264786	259591	rs556333401	NC_000017.11:43102739:T:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1379G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209481	17	41254760	17	43102743	209481	206440	rs139218576	NC_000017.11:43102742:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1321G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209482	17	41254818	17	43102801	209482	206441	rs149949159	NC_000017.11:43102800:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1173dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264845	17	41254965 - 41254966	17	43102948 - 43102949	264845	259592	rs36085989	NC_000017.11:43102948:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1037T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209483	17	41255102	17	43103085	209483	206442	rs67060599	NC_000017.11:43103084:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+1028T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209484	17	41255111	17	43103094	209484	206443	rs35908185	NC_000017.11:43103093:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+868C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209485	17	41255271	17	43103254	209485	206444	rs184910839	NC_000017.11:43103253:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+280G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209486	17	41255859	17	43103842	209486	206445	rs8176137	NC_000017.11:43103841:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+64del	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000983028	17	41256075	17	43104058	983028	971078	rs72434991	NC_000017.11:43104057:AAAAAAAAAAAA:AAAAAAAAAAA	Deletion	intron variant	Benign	Aug 12, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+52_441+63del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264809	17	41256076 - 41256087	17	43104059 - 43104070	264809	259593	rs536390258	NC_000017.11:43104058:AAAAAAAAAAAGAAAAAAAAAA:AAAAAAAAAA	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+36_441+50del	BRCA1		not specified	VCV000439443	17	41256089 - 41256103	17	43104072 - 43104086	439443	433275	rs1168113546	NC_000017.11:43104071:AAAAAAAAAGAAAAGAA:AA	Deletion	intron variant	Benign	Nov 25, 2016	criteria provided, single submitter							
NM_007294.4(BRCA1):c.441+36_441+49del	BRCA1		not provided|not specified|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225705	17	41256090 - 41256103	17	43104073 - 43104086	225705	227569	rs373413425	NC_000017.11:43104072:AAAAAAAAGAAAAGAA:AA	Deletion	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+18CTT[6]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225704	17	41256101 - 41256103	17	43104084 - 43104086	225704	227570	rs147856441	NC_000017.11:43104083:AAGAAGAAGAAGAAGAAGAAGAA:AAGAAGAAGAAGAAGAAGAA	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.441+18C>T	BRCA1		not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000215873	17	41256121	17	43104104	215873	213332	rs371973519	NC_000017.11:43104103:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+17del	BRCA1		Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000462647	17	41256122	17	43104105	462647	468056	rs730881449	NC_000017.11:43104104:AAAA:AAA	Deletion	intron variant	Benign/Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+17T>C	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000182089	17	41256122	17	43104105	182089	180888	rs368415464	NC_000017.11:43104104:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.441+13G>A	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000378919	17	41256126	17	43104109	378919	376124	rs1057520408	NC_000017.11:43104108:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	BRCA1	E143K, E96K, E117K, E73K, E140K, E16K, E99K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037580	17	41256153	17	43104136	37580	46136	rs80356991	NC_000017.11:43104135:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.425C>A (p.Pro142His)	BRCA1	P142H, P95H, P116H, P139H, P15H, P72H, P98H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000041823	17	41256155	17	43104138	41823	50262	rs55971303	NC_000017.11:43104137:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.397C>T (p.Arg133Cys)	BRCA1	R133C, R86C, R107C, R63C, R6C, R130C, R89C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055067	17	41256183	17	43104166	55067	69734	rs80357457	NC_000017.11:43104165:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	BRCA1	N132K, N85K, N129K, N5K, N62K, N88K, N106K	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000055064	17	41256184	17	43104167	55064	69731	rs80357413	NC_000017.11:43104166:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.370A>G (p.Ile124Val)	BRCA1	I124V, I77V, I121V, I80V, I54V, I98V	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054971	17	41256210	17	43104193	54971	69638	rs80357448	NC_000017.11:43104192:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.314A>G (p.Tyr105Cys)	BRCA1	Y105C, Y58C, Y35C, Y102C, Y61C, Y79C	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054780	17	41256266	17	43104249	54780	69447	rs28897673	NC_000017.11:43104248:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	BRCA1	A102G, A55G, A76G, A99G, A58G, A32G	BRCA1-related cancer predisposition	VCV000037505	17	41256275	17	43104258	37505	46061	rs80357190	NC_000017.11:43104257:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.302-41T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264792	17	41256319	17	43104302	264792	259594	rs8176135	NC_000017.11:43104301:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.302-70G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209487	17	41256348	17	43104331	209487	206446	rs147809611	NC_000017.11:43104330:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.301+55G>A	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000433688	17	41256830	17	43104813	433688	427571	rs868735744	NC_000017.11:43104812:C:T	single nucleotide variant	intron variant	Benign	May 28, 2019	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.301+20dup	BRCA1		not provided	VCV001286192	17	41256864 - 41256865	17	43104847 - 43104848	1286192	1276030	rs778150461	NC_000017.11:43104847:TT:TTT	Duplication	intron variant	Benign	Apr 1, 2015	criteria provided, single submitter							
NM_007294.4(BRCA1):c.301+12A>C	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000216660	17	41256873	17	43104856	216660	213334	rs863224757	NC_000017.11:43104855:T:G	single nucleotide variant	intron variant	Benign/Likely benign	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.301+8T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125666	17	41256877	17	43104860	125666	131204	rs80358101	NC_000017.11:43104859:A:G	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.301+7G>A	BRCA1		BRCA1-related cancer predisposition	VCV000037499	17	41256878	17	43104861	37499	46055	rs80358113	NC_000017.11:43104860:C:T	single nucleotide variant	intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.267C>A (p.Ile89=)	BRCA1		Hereditary cancer-predisposing syndrome	VCV000865349	17	41256919	17	43104902	865349	854485	rs80356963	NC_000017.11:43104901:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Mar 27, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.252A>G (p.Glu84=)	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000868313	17	41256934	17	43104917	868313	854518	rs2054685385	NC_000017.11:43104916:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Jul 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.213-161A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125614	17	41257134	17	43105117	125614	131152	rs799912	NC_000017.11:43105116:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.213-266A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209488	17	41257239	17	43105222	209488	206447	rs8176134	NC_000017.11:43105221:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.213-485T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209489	17	41257458	17	43105441	209489	206448	rs8176133	NC_000017.11:43105440:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+657A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209490	17	41257816	17	43105799	209490	206449	rs8176132	NC_000017.11:43105798:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+430G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209491	17	41258043	17	43106026	209491	206450	rs8176130	NC_000017.11:43106025:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+325T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209492	17	41258148	17	43106131	209492	206451	rs55974475	NC_000017.11:43106130:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+23T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000188404	17	41258450	17	43106433	188404	186551	rs8176128	NC_000017.11:43106432:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.212+4T>C	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000183921	17	41258469	17	43106452	183921	185123	rs398122652	NC_000017.11:43106451:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.201T>C (p.Asp67=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000427246	17	41258484	17	43106467	427246	416536	rs80357033	NC_000017.11:43106466:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	BRCA1	D67Y, D20Y	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054431	17	41258486	17	43106469	54431	69098	rs80357102	NC_000017.11:43106468:C:A	single nucleotide variant	missense variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-23CTTT[2]	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	VCV000240772	17	41258562 - 41258565	17	43106545 - 43106548	240772	242818	rs878854931	NC_000017.11:43106544:AAAGAAAGAAAGAA:AAAGAAAGAA	Microsatellite	intron variant	Benign/Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.135-23C>T	BRCA1		Hereditary breast ovarian cancer syndrome	VCV000548719	17	41258573	17	43106556	548719	539367	rs763633355	NC_000017.11:43106555:G:A	single nucleotide variant	intron variant	Benign	Apr 19, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.135-332C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264831	17	41258882	17	43106865	264831	259595	rs186268206	NC_000017.11:43106864:G:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-396A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209493	17	41258946	17	43106929	209493	206452	rs799913	NC_000017.11:43106928:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-499G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209494	17	41259049	17	43107032	209494	206453	rs8176126	NC_000017.11:43107031:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-563C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264811	17	41259113	17	43107096	264811	259596	rs575589035	NC_000017.11:43107095:G:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-766C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209495	17	41259316	17	43107299	209495	206454	rs12946839	NC_000017.11:43107298:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-925T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209496	17	41259475	17	43107458	209496	206455	rs148341992	NC_000017.11:43107457:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-1006G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209497	17	41259556	17	43107539	209497	206456	rs8176124	NC_000017.11:43107538:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-1231G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209498	17	41259781	17	43107764	209498	206457	rs799914	NC_000017.11:43107763:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-1803dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264791	17	41260352 - 41260353	17	43108335 - 43108336	264791	259597	rs34608699	NC_000017.11:43108335:AAAAAAAAAAAAAA:AAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2258T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209499	17	41260808	17	43108791	209499	206458	rs4792977	NC_000017.11:43108790:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2435C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209500	17	41260985	17	43108968	209500	206459	rs142808159	NC_000017.11:43108967:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2458G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209501	17	41261008	17	43108991	209501	206460	rs146059433	NC_000017.11:43108990:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2524_135-2509dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264813	17	41261058 - 41261059	17	43109041 - 43109042	264813	259598	rs146934045	NC_000017.11:43109041:CTATCTATCTACCTACCTATCTATCT:CTATCTATCTACCTACCTATCTATCTACCTACCTATCTATCT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2555C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209502	17	41261105	17	43109088	209502	206461	rs8176121	NC_000017.11:43109087:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-2683G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209503	17	41261233	17	43109216	209503	206462	rs8176120	NC_000017.11:43109215:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3013T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209504	17	41261563	17	43109546	209504	206463	rs8065872	NC_000017.11:43109545:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3390G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264804	17	41261940	17	43109923	264804	259599	rs187354131	NC_000017.11:43109922:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3551G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209505	17	41262101	17	43110084	209505	206464	rs142024941	NC_000017.11:43110083:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3552C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209506	17	41262102	17	43110085	209506	206465	rs8176119	NC_000017.11:43110084:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3641C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209507	17	41262191	17	43110174	209507	206466	rs111572667	NC_000017.11:43110173:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3759A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209508	17	41262309	17	43110292	209508	206467	rs113127132	NC_000017.11:43110291:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3807T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209509	17	41262357	17	43110340	209509	206468	rs111615606	NC_000017.11:43110339:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-3999C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209510	17	41262549	17	43110532	209510	206469	rs75129942	NC_000017.11:43110531:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-4161C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209511	17	41262711	17	43110694	209511	206470	rs73321427	NC_000017.11:43110693:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-4494T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209512	17	41263044	17	43111027	209512	206471	rs12936316	NC_000017.11:43111026:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.135-4533T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209513	17	41263083	17	43111066	209513	206472	rs147766773	NC_000017.11:43111065:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+4313C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209514	17	41263430	17	43111413	209514	206473	rs8176118	NC_000017.11:43111412:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+4294A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209515	17	41263449	17	43111432	209515	206474	rs188719262	NC_000017.11:43111431:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+4177A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209516	17	41263566	17	43111549	209516	206475	rs8176117	NC_000017.11:43111548:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+4133C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209517	17	41263610	17	43111593	209517	206476	rs143757906	NC_000017.11:43111592:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+3898T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209518	17	41263845	17	43111828	209518	206477	rs8176116	NC_000017.11:43111827:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+3597C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209519	17	41264146	17	43112129	209519	206478	rs11657823	NC_000017.11:43112128:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+3404C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209520	17	41264339	17	43112322	209520	206479	rs187294938	NC_000017.11:43112321:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+3379T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209521	17	41264364	17	43112347	209521	206480	rs8176114	NC_000017.11:43112346:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+3004G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264785	17	41264739	17	43112722	264785	259600	rs55737636	NC_000017.11:43112721:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+3001_134+3002del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264798	17	41264741 - 41264742	17	43112724 - 43112725	264798	259601	rs55820479	NC_000017.11:43112723:GA:	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2999del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264780	17	41264744	17	43112727	264780	259602	rs374842106	NC_000017.11:43112726:T:	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2994G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264823	17	41264749	17	43112732	264823	259603	rs377611452	NC_000017.11:43112731:C:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2993T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264824	17	41264750	17	43112733	264824	259604	rs371133200	NC_000017.11:43112732:A:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2990G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264819	17	41264753	17	43112736	264819	259605	rs375673256	NC_000017.11:43112735:C:T	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2983_134+2987del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264846	17	41264756 - 41264760	17	43112739 - 43112743	264846	259606	rs67177158	NC_000017.11:43112738:GAAAC:	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2672A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209522	17	41265071	17	43113054	209522	206481	rs113210086	NC_000017.11:43113053:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2570A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209523	17	41265173	17	43113156	209523	206482	rs138040784	NC_000017.11:43113155:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+2349GAAAA[2]	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264825	17	41265380 - 41265384	17	43113363 - 43113367	264825	259607	rs139811854	NC_000017.11:43113362:TTTTCTTTTCTTTTCTTTT:TTTTCTTTTCTTTT	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1967T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209524	17	41265776	17	43113759	209524	206483	rs8176109	NC_000017.11:43113758:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1936C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209525	17	41265807	17	43113790	209525	206484	rs8176108	NC_000017.11:43113789:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1788C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209526	17	41265955	17	43113938	209526	206485	rs2671874	NC_000017.11:43113937:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1704dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209527	17	41266038 - 41266039	17	43114021 - 43114022	209527	206486	rs113808892	NC_000017.11:43114021:CC:CCC	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1651dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264800	17	41266091 - 41266092	17	43114074 - 43114075	264800	259608	rs541592598	NC_000017.11:43114074:AAAAAAAAAAAAA:AAAAAAAAAAAAAA	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1632C>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209528	17	41266111	17	43114094	209528	206487	rs8176106	NC_000017.11:43114093:G:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1391C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209529	17	41266352	17	43114335	209529	206488	rs79415432	NC_000017.11:43114334:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+1335dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264777	17	41266407 - 41266408	17	43114390 - 43114391	264777	259609	rs35851659	NC_000017.11:43114390:TTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+746G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209530	17	41266997	17	43114980	209530	206489	rs8176104	NC_000017.11:43114979:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+693C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209531	17	41267050	17	43115033	209531	206490	rs8176103	NC_000017.11:43115032:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+563G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209532	17	41267180	17	43115163	209532	206491	rs8176102	NC_000017.11:43115162:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+296C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209533	17	41267447	17	43115430	209533	206492	rs139405471	NC_000017.11:43115429:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+224dup	BRCA1		not provided	VCV001255252	17	41267518 - 41267519	17	43115501 - 43115502	1255252	1245184	rs35149296	NC_000017.11:43115501:AAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 19, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.134+224del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264828	17	41267519	17	43115502	264828	259610	rs35149296	NC_000017.11:43115501:AAAAAAAAAAAAAAA:AAAAAAAAAAAAAA	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+202A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209534	17	41267541	17	43115524	209534	206493	rs8176101	NC_000017.11:43115523:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+111C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209535	17	41267632	17	43115615	209535	206494	rs8176100	NC_000017.11:43115614:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.134+4A>G	BRCA1		Hereditary cancer-predisposing syndrome	VCV000867838	17	41267739	17	43115722	867838	855794	rs1555599189	NC_000017.11:43115721:T:C	single nucleotide variant	intron variant	Benign	Jan 29, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.133A>C (p.Lys45Gln)	BRCA1	K45Q	Breast-ovarian cancer, familial, susceptibility to, 1	VCV000183950	17	41267744	17	43115727	183950	185127	rs769650474	NC_000017.11:43115726:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.114G>A (p.Lys38=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000054146	17	41267763	17	43115746	54146	68813	rs1800062	NC_000017.11:43115745:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-11T>C	BRCA1		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000632617	17	41267807	17	43115790	632617	621051	rs767144634	NC_000017.11:43115789:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-12dup	BRCA1		not specified|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome	VCV000125523	17	41267807 - 41267808	17	43115790 - 43115791	125523	131061	rs273902789	NC_000017.11:43115790:GGGGGGG:GGGGGGGG	Duplication	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-11del	BRCA1		BRCA1-related cancer predisposition	VCV000037699	17	41267807	17	43115790	37699	46255	rs273902788	NC_000017.11:43115789:A:	Deletion	intron variant	Benign	Jun 11, 2024	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-12del	BRCA1		Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000091667	17	41267808	17	43115791	91667	97144	rs273902789	NC_000017.11:43115790:GGGGGGG:GGGGGG	Deletion	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-12C>G	BRCA1		not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000091666	17	41267808	17	43115791	91666	97143	rs80358055	NC_000017.11:43115790:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-13C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037701	17	41267809	17	43115792	37701	46257	rs56328013	NC_000017.11:43115791:G:C	single nucleotide variant	intron variant	Benign	Aug 10, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-13C>A	BRCA1		Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037700	17	41267809	17	43115792	37700	46256	rs56328013	NC_000017.11:43115791:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-14C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000037702	17	41267810	17	43115793	37702	46258	rs80358006	NC_000017.11:43115792:G:A	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-17C>G	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|not specified	VCV000215877	17	41267813	17	43115796	215877	213340	rs757442952	NC_000017.11:43115795:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-20C>T	BRCA1		not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125525	17	41267816	17	43115799	125525	131063	rs80358039	NC_000017.11:43115798:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-65G>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125526	17	41267861	17	43115844	125526	131064	rs80358117	NC_000017.11:43115843:C:G	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-189A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209536	17	41267985	17	43115968	209536	206495	rs113046417	NC_000017.11:43115967:T:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-410T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209537	17	41268206	17	43116189	209537	206496	rs8176098	NC_000017.11:43116188:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-414_81-413dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264838	17	41268208 - 41268209	17	43116191 - 43116192	264838	259611	rs8176097	NC_000017.11:43116191:TTTTTTTT:TTTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-413dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264808	17	41268208 - 41268209	17	43116191 - 43116192	264808	259612	rs8176097	NC_000017.11:43116191:TTTTTTTT:TTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-508A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264841	17	41268304	17	43116287	264841	259613	rs562162183	NC_000017.11:43116286:T:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-672C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209538	17	41268468	17	43116451	209538	206497	rs114323360	NC_000017.11:43116450:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-802G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209539	17	41268598	17	43116581	209539	206498	rs8074462	NC_000017.11:43116580:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-950C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209540	17	41268746	17	43116729	209540	206499	rs8176095	NC_000017.11:43116728:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-1202T>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209541	17	41268998	17	43116981	209541	206500	rs148120486	NC_000017.11:43116980:A:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-1384G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209542	17	41269180	17	43117163	209542	206501	rs117381683	NC_000017.11:43117162:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-1519G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209543	17	41269315	17	43117298	209543	206502	rs138795459	NC_000017.11:43117297:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-1947A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264839	17	41269743	17	43117726	264839	259614	rs190387252	NC_000017.11:43117725:T:C	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2286A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209544	17	41270082	17	43118065	209544	206503	rs147420429	NC_000017.11:43118064:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2433A>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209545	17	41270229	17	43118212	209545	206504	rs8176092	NC_000017.11:43118211:T:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2439C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209546	17	41270235	17	43118218	209546	206505	rs149469770	NC_000017.11:43118217:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2481G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209547	17	41270277	17	43118260	209547	206506	rs8176091	NC_000017.11:43118259:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2559A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209548	17	41270355	17	43118338	209548	206507	rs9895855	NC_000017.11:43118337:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2622C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209549	17	41270418	17	43118401	209549	206508	rs8176090	NC_000017.11:43118400:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2646C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209550	17	41270442	17	43118425	209550	206509	rs8176089	NC_000017.11:43118424:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2667C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209551	17	41270463	17	43118446	209551	206510	rs8176088	NC_000017.11:43118445:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2870G>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209552	17	41270666	17	43118649	209552	206511	rs8176087	NC_000017.11:43118648:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-2983dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264797	17	41270778 - 41270779	17	43118761 - 43118762	264797	259615	rs35150209	NC_000017.11:43118761:TTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-3255C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209553	17	41271051	17	43119034	209553	206512	rs73321445	NC_000017.11:43119033:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-3426G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209554	17	41271222	17	43119205	209554	206513	rs143912779	NC_000017.11:43119204:C:T	single nucleotide variant	intron variant|5 prime UTR variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.81-3498del	BRCA1		not provided	VCV001270684	17	41271294	17	43119277	1270684	1261821	rs61461583	NC_000017.11:43119276:AAAAAAAAAAAA:AAAAAAAAAAA	Deletion	intron variant	Benign	Oct 21, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.81-3625del	BRCA1		not provided|Hereditary cancer-predisposing syndrome	VCV001678798	17	41271421	17	43119404	1678798	1670592	rs373185847	NC_000017.11:43119403:G:	Deletion	intron variant	Benign/Likely benign	Jan 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.81-3636C>T	BRCA1		not provided|Hereditary cancer-predisposing syndrome	VCV001678799	17	41271432	17	43119415	1678799	1670593	rs140591536	NC_000017.11:43119414:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.80+4068T>C	BRCA1|LOC110485084|LOC111589216		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264781	17	41271966	17	43119949	264781	259616	rs532039683	NC_000017.11:43119948:A:G	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+4041C>G	BRCA1|LOC110485084|LOC111589216		Hereditary cancer-predisposing syndrome	VCV001692978	17	41271993	17	43119976	1692978	1685418	rs186936074	NC_000017.11:43119975:G:C	single nucleotide variant	intron variant	Benign	Mar 29, 2021	criteria provided, single submitter							
NM_007294.4(BRCA1):c.80+3724C>G	BRCA1|LOC110485084		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209555	17	41272310	17	43120293	209555	206514	rs116806238	NC_000017.11:43120292:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+3207A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209556	17	41272827	17	43120810	209556	206515	rs192816557	NC_000017.11:43120809:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+3038C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209557	17	41272996	17	43120979	209557	206516	rs146467457	NC_000017.11:43120978:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+3011C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209558	17	41273023	17	43121006	209558	206517	rs112674337	NC_000017.11:43121005:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+2939C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209559	17	41273095	17	43121078	209559	206518	rs35668327	NC_000017.11:43121077:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+2786G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209560	17	41273248	17	43121231	209560	206519	rs142831199	NC_000017.11:43121230:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+2686A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209561	17	41273348	17	43121331	209561	206520	rs799902	NC_000017.11:43121330:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+2655C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209562	17	41273379	17	43121362	209562	206521	rs34942571	NC_000017.11:43121361:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+2612G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209563	17	41273422	17	43121405	209563	206522	rs148068102	NC_000017.11:43121404:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+2497T>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209564	17	41273537	17	43121520	209564	206523	rs36086436	NC_000017.11:43121519:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+1470A>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264835	17	41274564	17	43122547	264835	259617	rs541281969	NC_000017.11:43122546:T:A	single nucleotide variant	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+1256C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209565	17	41274778	17	43122761	209565	206524	rs8176086	NC_000017.11:43122760:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+1245G>A	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209566	17	41274789	17	43122772	209566	206525	rs8176085	NC_000017.11:43122771:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+1128C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209568	17	41274906	17	43122889	209568	206526	rs799903	NC_000017.11:43122888:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+1128del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209567	17	41274906	17	43122889	209567	206527	rs199839105	NC_000017.11:43122888:G:	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+952dup	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209569	17	41275081 - 41275082	17	43123064 - 43123065	209569	206528	rs149141411	NC_000017.11:43123064:AAAAAAAAA:AAAAAAAAAA	Duplication	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+883C>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209570	17	41275151	17	43123134	209570	206529	rs8176083	NC_000017.11:43123133:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+389T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209571	17	41275645	17	43123628	209571	206530	rs8176082	NC_000017.11:43123627:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+379C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209572	17	41275655	17	43123638	209572	206531	rs113117695	NC_000017.11:43123637:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.80+202C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209573	17	41275832	17	43123815	209573	206532	rs8176079	NC_000017.11:43123814:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.21C>T (p.Arg7=)	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000136537	17	41276093	17	43124076	136537	140240	rs149402012	NC_000017.11:43124075:G:A	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Benign	Jun 29, 2017	reviewed by expert panel							
NM_007294.4(BRCA1):c.-19-3A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125471	17	41276135	17	43124118	125471	131009	rs273898669	NC_000017.11:43124117:T:C	single nucleotide variant	intron variant	Benign	Jun 18, 2019	reviewed by expert panel							
NM_007294.4(BRCA1):c.-19-10T>C	BRCA1		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000125467	17	41276142	17	43124125	125467	131005	rs201866997	NC_000017.11:43124124:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.-19-32AT[7]	BRCA1		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	VCV000225725	17	41276152 - 41276153	17	43124135 - 43124136	225725	227571	rs273898667	NC_000017.11:43124135:ATATATATATAT:ATATATATATATAT	Microsatellite	intron variant	Benign/Likely benign	Nov 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_007294.4(BRCA1):c.-19-85_-19-81del	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264773	17	41276213 - 41276217	17	43124196 - 43124200	264773	259618	rs56209245	NC_000017.11:43124195:TAAAGTAAA:TAAA	Deletion	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.-19-109A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 2	VCV004073519	17	41276241	17	43124224	4073519	4187336		NC_000017.11:43124223:T:C	single nucleotide variant	intron variant|5 prime UTR variant	Benign	Jul 18, 2025	criteria provided, single submitter							
NM_007294.4(BRCA1):c.-19-115T>C	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000125468	17	41276247	17	43124230	125468	131006	rs3765640	NC_000017.11:43124229:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-19-216A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209574	17	41276348	17	43124331	209574	206533	rs8176077	NC_000017.11:43124330:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-19-361C>T	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209575	17	41276493	17	43124476	209575	206534	rs141625477	NC_000017.11:43124475:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-20+530G>A	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209576	17	41276758	17	43124741	209576	206535	rs111462026	NC_000017.11:43124740:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-20+494CAAAA[5]	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000264850	17	41276765 - 41276769	17	43124748 - 43124752	264850	259619	rs572878542	NC_000017.11:43124747:TTTTGTTTTGTTTTGTTTTGTTTTGTTTTG:TTTTGTTTTGTTTTGTTTTGTTTTG	Microsatellite	intron variant	Benign	Sep 28, 2016	reviewed by expert panel							
NM_007294.4(BRCA1):c.-20+336C>T	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209577	17	41276952	17	43124935	209577	206536	rs8176076	NC_000017.11:43124934:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-20+185T>G	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209578	17	41277103	17	43125086	209578	206537	rs55680227	NC_000017.11:43125085:A:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-20+152A>G	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000803421	17	41277136	17	43125119	803421	791775	rs1412775379	NC_000017.11:43125118:T:C	single nucleotide variant	intron variant	Benign	May 28, 2019	criteria provided, single submitter							
NM_007294.4(BRCA1):c.-20+101C>G	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000189123	17	41277187	17	43125170	189123	186980	rs799905	NC_000017.11:43125169:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.4(BRCA1):c.-20+11C>T	BRCA1|LOC111589215		Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	VCV000125464	17	41277277	17	43125260	125464	131002	rs273898672	NC_000017.11:43125259:G:A	single nucleotide variant	non-coding transcript variant|intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_007294.3(BRCA1):c.-127C>A	BRCA1|LOC111589215		not provided	VCV002682149	17	41277395	17	43125378	2682149	2843181	rs938827457	NC_000017.11:43125377:G:T	single nucleotide variant	intron variant	Benign	Apr 30, 2022	criteria provided, single submitter							
NM_007294.4(BRCA1):c.-192T>C	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209579	17	41277460	17	43125443	209579	206538	rs113323025	NC_000017.11:43125442:A:G	single nucleotide variant		Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-273G>A	BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209580	17	41277541	17	43125524	209580	206539	rs112960339	NC_000017.11:43125523:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-728A>G	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209581	17	41277996	17	43125979	209581	206540	rs3092986	NC_000017.11:43125978:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NC_000017.11:g.43126099T>C	BRCA1|LOC111589215|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209582	17	41278116	17	43126099	209582	206541	rs799906	NC_000017.11:43126098:T:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NC_000017.11:g.43126360G>A	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209583	17	41278377	17	43126360	209583	206542	rs11655505	NC_000017.11:43126359:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-1457G>C	BRCA1|LOC111589215|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209584	17	41278725	17	43126708	209584	206543	rs799907	NC_000017.11:43126707:C:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-1465G>A	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209585	17	41278733	17	43126716	209585	206544	rs36221744	NC_000017.11:43126715:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-1619G>A	BRCA1|LOC111589215|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209586	17	41278887	17	43126870	209586	206545	rs144412026	NC_000017.11:43126869:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-1648T>C	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209587	17	41278916	17	43126899	209587	206546	rs799908	NC_000017.11:43126898:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-1959C>T	BRCA1|LOC111589215|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209588	17	41279227	17	43127210	209588	206547	rs799909	NC_000017.11:43127209:G:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2030T>C	BRCA1|LOC111589215|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209589	17	41279298	17	43127281	209589	206548	rs4793204	NC_000017.11:43127280:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2261T>C	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209590	17	41279529	17	43127512	209590	206549	rs183796323	NC_000017.11:43127511:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2266G>A	BRCA1|LOC111589215|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209591	17	41279534	17	43127517	209591	206550	rs8077035	NC_000017.11:43127516:C:T	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2293C>G	NBR2|BRCA1|LOC111589215		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209592	17	41279561	17	43127544	209592	206551	rs799910	NC_000017.11:43127543:G:C	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2502T>C	BRCA1|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209593	17	41279770	17	43127753	209593	206552	rs34410138	NC_000017.11:43127752:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2569G>T	BRCA1|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209594	17	41279837	17	43127820	209594	206553	rs35981166	NC_000017.11:43127819:C:A	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2614T>C	BRCA1|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209595	17	41279882	17	43127865	209595	206554	rs12947782	NC_000017.11:43127864:A:G	single nucleotide variant	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3(BRCA1):c.-2617_-2616del	BRCA1|NBR2		Breast-ovarian cancer, familial, susceptibility to, 1	VCV000209596	17	41279884 - 41279885	17	43127867 - 43127868	209596	206555	rs112881775	NC_000017.11:43127866:ACA:A	Deletion	intron variant	Benign	Jan 12, 2015	reviewed by expert panel							
NM_007294.3:c.547+68A>G	BRCA1		Breast-ovarian cancer, familial, susceptibility to, 2	VCV004057255					4057255	4171186			single nucleotide variant		Benign	Jul 17, 2025	criteria provided, single submitter							
NM_007294.3:c.441+6insA	BRCA1		Familial cancer of breast	VCV000182086					182086	181130			Insertion		Benign	Jul 2, 2014	criteria provided, single submitter							
NM_007294.3:c.134+19insT	BRCA1		Familial cancer of breast	VCV000182083					182083	181129			Insertion		Benign	Jul 8, 2014	criteria provided, single submitter							
